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ABSTRACT 
THE EFFECT OF CERVICAL CANCER ON SURVIVOR'S SEXUAL 
DYSFUNCTION AND QUALITY OF LIFE 
Katie F. Myatt 
April 18,2013 
Cervical cancer poses a unique opportunity for researchers who are interested in 
quality of life. It is one of the most common cancers, has a very high survival rate, and 
very little research has been conducted to determine the effects of cervical cancer on 
women post-diagnosis. This goal of this thesis was to determine if cervical cancer 
survivors were at greater risk of sexual dysfunction due to treatment or stage of disease 
and to determine if poorer quality of life outcomes were associated with sexual 
dysfunction and depression. The results found that stage and treatment options put 
survivors at greater risk for sexual dysfunction and that sexual dysfunction and 
depression were associated with poorer mental and physical quality of life. 
IV 
T ABLE OF CONTENTS 
DEDICATION ....................................................... " ........................................................... iii 
ABSTRACT ........................................................... " ........................................................... iv 
LIST OF TABLES ................................................. " ......................................................... viii 
Chapter ................................................................... " ....................................................... Page 
1. INTRODUCTION ................................. " ............................................................. 1 
2. BACKGROUND ................................... " ............................................................. 3 
2.1 Epidemiology of Cervical Cancer.. ........................................................ 3 
2.1.1 Risk Factors .............. " ............................................................. 3 
2.1.2 Prevention of Human Papilloma 
Virus (HPV) Infection ........ " ............................................................. 4 
2.1.3 Treatment .................. " ............................................................. 4 
2.1.4 Survival ..................... " ............................................................. 5 
2.2 Quality of Life Issues (Overview) ......................................................... 6 
2.2.1 Sexual Dysfunction ... " ............................................................. 8 
2.2.l.1 Assessing the Impact 
of Diagnosis with the 
Sexual Adjustment Questionnaire (SAQ) ............................ 9 
2.2.2 Assessing Quality of Life with 
the MOS 36-item Short Form Survey (SF-36) .............................. 10 
2.3 Covariates ................................ " ........................................................... 13 
2.3.1 Depression ................. " ........................................................... 13 
2.3.1.1 Impact of Diagnosis with 
Relation to the Center for 
Epidemiologic Studies-Depression 
(CES-D) Scale .................................................................... 13 
3. METHODS ............................................ " ........................................................... 15 
3.1 Study Description ................................................................................. 15 
v 
3.2 Data Collection .................................................................................... 16 
3.2.1 New Mexico 
Tumor Registry (NMTR) ............................................................... 16 
3.2.2 Questionnaire ........................................................................ 17 
3.2.3 MOS 36-item Short Form 
Survey (SF-36), Center for Epidemiologic 
Studies-Depression (CES-D) Scale, 
and Charlson Comorbidity Index ................................................... 17 
3.2.3.1 SF-36 ...................................................................... 17 
3.2.3.2 CES-D .................................................................... 18 
3.2.3.3 Charlson Co morbidity Index .................................. 19 
3.2.4 Measures of Sexual Dysfunction .......................................... 20 
3.3 Statistical Plan .......................... " ........................................................... 21 
3.3.1 Logistic Regression Models .................................................. 22 
3.3.2 Linear Regression Model ...................................................... 23 
3.4 Power ....................................... " ........................................................... 23 
3.4.1 Logistic Regression ............................................................... 24 
3.4.2 Linear Regression ................................................................. 24 
4. RESULTS .......................................................................................................... 26 
4.1 Descriptive Characteristics of the Sample ........................................... 26 
4.1.1 Demographics ....................................................................... 26 
4.1.2 Behavioral and Physical 
Characteristics ................................................................................ 30 
4.1.3 Other Covariates of Interest .................................................. 33 
4.1.4 Outcome Variables ................................................................ 35 
4.1.4.1 Secondary Aim ....................................................... 36 
4.2 Sexual Dysfunction, Stage of Disease, 
and Radiation Therapy ............................................................................... 37 
4.3 Depression and Stage of Disease ........................................................ .45 
4.4 MOS 36-item Short Form Survey (SF-36) 
Physical and Mental Health Summary Scores ........................................... 50 
4.4.1 Physical Health Summary Score, 
Depression, and Sexual Dysfunction ............................................. 50 
VI 
4.4.2 Mental Health Summary Score, 
Depression, and Sexual Dysfunction ............................................. 55 
5. DISCUSSION ..................................................................................................... 60 
5.1 Associations with Sexual Dysfunction ................................................ 60 
5.1.1 The a priori Hypotheses ....................................................... 60 
5.1.2 Focusing on the Relationship Between 
Sexual Function, Stage of Disease, and Depression ...................... 61 
5.2 Quality of Life and the MOS 36-item 
Short Form Survey (SF-36) ........................................................................ 63 
5.3 Strengths and Limitations ..................................................................... 64 
5.3.1 Limitations ............................................................................. 64 
5.3.2 Strengths ................................................................................ 64 
5.4 Future Implications .............................................................................. 65 
REFERENCES ................................................................................................................... 67 
APPENDIX 
A. VARIABLE DESCRIPTIONS AND CODING ............................................... 72 
B. CERVICAL CANCER STUDIES .................................................................... 81 
C. SEXUAL HISTORY QUESTIONS AND RESPONSES ................................. 89 
D. TREATMENT OPTIONS BY STAGE OF DISEASE ................................... 92 
CURRICULUM VITAE .................................................................................................... 94 
VB 
LIST OF TABLES 
Table ........................................................................................................................................... Page 
4.1 Demographic Characteristics of Sample by Stage ......................................................... , ......... 27 
4.2 Physical and Behavioral Characteristics of 
Survivors by Stage of Cervical Cancer .......................................................................................... 31 
4.3 Treatment Options by Stage of Cervical Cancer. ............................................................... '" ... 33 
4.4 Charlson Comorbidity Index by Stage ........................................................................... , ......... 34 
4.5 Self-Reported Quality of Life by Stage of Cervical Cancer ..................................................... 34 
4.6 Subject's CES-D Scores by Stage ............................................................................................. 35 
4.7 Effect of Cervical Cancer on Sexual 
Relationship by Stage ..................................................................................................................... 36 
4.8 Univariate Models Describing the Effects 
on Sexual Dysfunction ................................................................................................................... 37 
4.9 Models Used to Describe 
the Effect of Radiation Therapy on Sexual Dysfunction ............................................................... .41 
4.10 Models Used to Describe the 
Effect of Stage of Cervical Cancer on Sexual Dysfunction .......................................................... .43 
4.11 Univariate Models Describing the Effects on Depression .................................................... .45 
4.12 Models Used to Describe the Effect of Stage 
of Cervical Cancer on Depression .................................................................................................. 48 
4.13 Univariate Models Describing the Effects on the 
SF-36 Physical Health Summary Score ......................................................................................... 51 
4.14 Models Describing the Effect on 
Cervical Cancer Survivor's SF-36 Physical Health Score ............................................................. 53 
4.15 Univariate Models Describing the Effect on the 
SF-36 Mental Health Summary Score ............................................................................................ 56 
4.16 Models Describing the Effect on 




Cervical cancer is characterized as a malignancy in the cervix: the part of the 
body that connects the uterus to the vagina. (American Society of Clinical Oncology, 
2012) A very slow progressing cancer, abnormal cells (that are often eliminated by the 
body with no treatment) can eventually lead to cervical cancer in patients depending on 
certain risk factors. It is now established that infection with Human Papilloma Virus 
(HPV) is causally associated with most cervical cancer diagnoses. (Eifel, Berek & 
Thigpen, 2001) 
Cervical cancer is one of the most common forms of cancer worldwide with 86% 
of cases occurring in the developing world where the age-adjusted incidence rate is 
17.811 00,000 cases per year. (World Health Organization, 2010; World Health 
Organization, 2013) In the U.S, 8.1/100,000 women are diagnosed with cervical cancer 
every year. This ranks cervical cancer as the 13th leading cancer in all women of North 
America. (World Health Organization, 2010) 
The 2009 prevalence of cervical cancer, in the United States, was 247,711. As of 
2012, it is estimated that 12,170 women will be diagnosed and 4,200 will die from the 
disease. (Siegel, R., Deepa, N., & Ahmedin, J., 2012; Howlander et aI., 2012) Given that 
the overall five-year survival rate is 67.9%, the demand for research into cervical disease 
is high. (Howlander et aI., 2012) 
Not only is the burden of disease cause for research, but cervical cancer can affect 
all areas of a woman's life. In a review of issues surrounding quality of life and cervical 
cancer survivors, Vistad, Fossa, & Dahl (2006) define health-related quality of life as the 
"survivor's self-reported physical, psychosocial, and sexual well-being." This broad 
definition encompasses many of the problems of cervical cancer survivorship. For 
example, cervical cancer literature describes all of the following: physical impairments, 
pain and fatigue, depression, and sexual dysfunction. (Basson, 2005; Bodurka & Sun, 
2006; Goncalves, 2010) 
This thesis will examine issues related to the quality of life using data from a 
cohort of cervical cancer survivors. The primary objective is to determine if a cervical 
cancer diagnosis and the resulting treatment are associated with a poorer overall quality 
of life, greater sexual dysfunction and increased depression. In order to accomplish this 
objective, the study's primary aims are to compare cervical cancer survivors by type of 
diagnosis, (invasive versus in situ) and treatment type, for differences in overall quality 
of life, sexual dysfunction and depression. These differences will be quantified using 
measures such as the MOS 36-Item Short Form Survey (SF-36), Sexual Adjustment 
Questionnaire (SAQ), and the Center for Epidemiologic Studies Depression (CES-D) 
Scale while controlling for factors such as age, menopausal status, physical activity, 
comorbidity, body mass index (BMI), socioeconomic class, tobacco use and alcohol 
consumption. As a secondary aim the study will seek to determine whether individuals 
who respond to questions relating to depression using the Charlson Comorbidity Index 
also score as "depressed" using the CES-D. 
2 
2.1.1 Risk Factors 
CHAPTER 2 
BACKGROUND 
2.1 Epidemiology of Cervical Cancer 
--------------
Many risk factors are thought to playa role in the development of cervical cancer. 
For example, multiple sexual partners, tobacco use, immunodeficiency, vitamin A and C 
deficiencies, contraceptive use, HIV coinfection, coinfection with other sexually 
transmitted infections, parity, and genetic factors have all been discussed in the literature 
as increasing risk or promoting the progression of cervical disease. (World Health 
Organization, 2010; Eifel et aI., 2001) However, the major risk factor for cervical cancer 
is Human papillomavirus (HPV) infection. (Howlander et aI., 2012) 
According to the Centers for Disease Control and Prevention, HPV is the most 
common sexually transmitted infection in the United States. It is estimated that 79 
million people in the U.S. are infected with one of over 40 different strains of HPV, and 
14 million cases will develop each year. (Centers for Disease Control and Prevention, 
2012; Centers for Disease Control and Prevention, 2013) The severity of HPV infection 
ranges from low to high risk. Low risk strains often cause asymptomatic infections that 
may resolve without treatment and are often the cause of genital warts (strains 6 and 11 
cause about 90% of genital warts). Alternatively, high risk strains are often oncogenic. 
Currently, twelve oncogenic strains have been identified (strains 16 and 18 are 
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responsible for approximately 70% of cervical cancers). (National Cancer Institute, 2012; 
Howlander et aI., 2012) 
2.1.2 Prevention of Human Papilloma Virus (HPV) Infection 
Since the 1930's, death rates due to cervical cancer have decreased due to the 
implementation of routine screening programs. These programs have involved pelvic 
exams and cytological evaluations in the past, and eventually evolved to include the 
papanicolaou, or Pap, smear and HPV testing. (Eifel et aI., 2001; American Society of 
Clinical Oncology, 2012) Current cervical cancer prevention efforts are focused on 
preventing HPV infection through vaccination programs with Gardasil (quadrivalent 
vaccine) and Cervarix (bivalent) which both protect against HPV strains 16 and 18 
(Gardasil also protects against strains 6 and 11). The vaccines are recommended to all 
preteen girls in an effort to prevent infection before becoming sexually active (Gardasil is 
also recommended for preteen boys). (Advisory Committee on Immunization Practices 
[ACIP), 2011) Advisory Committee on Immunization Practices (ACIP) guidelines (2011) 
also recommend that women through the age of 26 and men through the age of 21 be 
vaccinated against HPV. (Markowitz et aI., 2007) 
2.1.3 Treatment 
The prescribed treatment can be very different from woman to woman, the 
variation being influenced by many factors. (Eifel et aI., 2001; The American Cancer 
Society, 2012) However, stage of disease is the most influential determinant in the 
woman's treatment. Women who have in situ disease are often treated with the same 
procedures as women who have pre-cancerous changes of the cervix. (The American 
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Cancer Society, 2012) However, when women are diagnosed with invasive disease, the 
treatment options must become more aggressive. 
There are four stages of invasive cervical cancer carcinomas and each stage has 
subcategories. Stage I cervical disease is confined to the cervix and each subcategory is 
based on invasion depth and tumor size. Stage II carcinomas extend past the cervix but 
have not infiltrated the pelvic wall. There are two stage II subcategories based on 
parametrial involvement. Stage III carcinomas have infiltrated the pelvic side wall and 
involve the lower third of the vagina. There are also two subcategories of stage III. These 
subcategories are determined by the presence of hydronephrosis or involvement of the 
lower third of the vagina. Stage IV disease has spread past the true pelvis or involves the 
bladder and/or rectum, and subcategories are based on the region of the body to which the 
cancer has spread. (Sobin, Gospodarowicz, & Wittekind, 2002) According to the 
American Cancer Society (2012), surgery is a standard treatment in stages I and II. In 
those stages it can also be combined with internal and external radiation and 
chemotherapy. (The American Cancer Society, 2012; Eifel et aI., 2001) Stage III and IV 
cancers are treated with radiation and chemotherapy. (The American Cancer Society, 
2012; Eifel et aI., 2001) For a listing of treatment options by stage see Appendix D. 
2.104 Survival 
Incidence and mortality of cervical cancer varies between the developed and 
developing world. In developing countries, cervical cancer is more common and 
mortality is higher. (Eifel et aI., 2001) In developed countries, where screening programs 
are more prevalent, rates of cervical cancer and cervical cancer deaths are lower. (Eifel et 
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aI., 2001) Nonetheless, even worldwide, when mortality is compared to incidence, 
mortality due to cervical cancer is low. (World Health Organization, 2010) 
In the United States, the age-adjusted death rate for cervical cancer patients is 2.4 
per 100,000 women. (Howlander et aI., 2012) In fact, when invasive disease is caught at 
its earliest stage, survival is near 100%. (Bartoces et aI., 2009) Therefore, there are an 
ever growing number of cervical cancer survivors who are faced with the burden of 
secondary health issues related to their cervical diagnosis and treatment. 
2.2 Quality of Life Issues (Overview) 
Beginning in the mid-20th century, the World Health Organization started to 
define health as more than just the absence of disease. (Testa & Simmonson, 1996) 
Physical, social, and mental well-being are all vital constructs in identifying an 
individual's physical or perceived health. Not only are quality of life studies used in the 
determination of treatment plans for individuals, but they are also used in the planning 
and development of medical programs and cost analyses. (Testa & Simmonson, 1996) 
Therefore, a thorough investigation of the issues surrounding quality of life is necessary 
in any study of disease. 
According to Testa and Simmonson (1996) quality of life can be defined as "The 
physical, psychological, and social domains of health, seen as distinct areas that are 
influenced by a person's experiences, beliefs, expectations, and perceptions." These 
"domains" are measured in two different scales, subjective and objective. Consequently, 
because of the subjective characteristic of quality of life there are challenges in 
quantifying quality of life. (Testa & Simmonson, 1996) 
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In the literature, measurement of quality of life varies among researchers. 
However, most separate the physical, psychological, and social domains and ask specific 
questions designed to elicit information on each. The answers to these questions are then 
analyzed in combination with objective factors such as symptoms to evaluate the 
individual within each domain. (Testa & Simmonson, 1996) These results are a necessity 
in a good body of research because the difference that quality of life has on a patient can 
change the entire course of illness. 
Not only has quality of life been recognized by the WHO, but quality of life 
studies have become particularly important in cancer research. As the number of 
individuals who survive cancer continues to increase, the need to know what challenges 
they will face throughout their lifetime increases. (Ferrell, Dow, & Grant, 1995) Ferrell et 
ai. (1995) give two reasons why quality of life studies have become such a necessity 
when investigating cancer: the increased number of survivors and the increased 
awareness of chronic diseases such as cancer. 
First, the improvement of treatment plans based on advanced medical technology 
and more efficient supportive care are major reasons as to why there is an increase in the 
number of cancer survivors. (Ferrell et aI., 1995) However, this often leaves cancer 
survivors with years of coping with difficult mental, physical, or well-being issues 
subsequent to their diagnosis and treatment. 
Secondly, as the number of cancer survivors grows, the "voice" that survivors 
have within our communities is increasing. (Ferrell et aI., 1995) Cancer survivors provide 
support through cancer-centered support groups, lobby for the health of others, and may 
be involved with the publication of materials on their disease. This awareness in the 
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community demands more research and change that better informs and supports a cancer 
SurVIVOr. 
This combination that Ferrell et ai. (1995) studied, has led to a large amount of 
literature that has sought and discovered many changes that affect quality of life. 
Specifically in cervical cancer research, mental and physical changes such as depression, 
self-esteem, body image, relationship changes, spiritual changes, physical differences in 
the woman's body, and sexual function have been revealed. 
The themes of this thesis, sexual dysfunction and overall quality of life, as 
measured by the Medical Outcomes Study 36-item Short Form Survey (SF-36), are very 
common themes in the literature. For many women, sexual dysfunction and its 
involvement in self-image and relationships, is a major priority. Similarly, the change in 
quality of life that a diagnosis of cervical cancer can have is of major concern. Especially, 
because the effects of cervical cancer can be faced for decades the woman is considered 
to be cancer-free. 
2.2.1 Sexual Dysfunction 
Sexual dysfunction is a common quality of life issue among cervical cancer 
survivors. In a review by Bodurka and Sun (2006) 50% of women diagnosed with 
gynecologic cancer were diagnosed with at least one indicator of sexual dysfunction. 
Treatment regimens and the disease itself can cause physiological changes that make sex 
difficult after diagnosis, and survival time has also been associated with sexual 
dysfunction. (Donovan et aI., 2007; Frumovitz et aI., 2005) 
Sexual dysfunction is defined in a variety of way throughout the literature. Many 
studies use frequency of sexual activity, desire, a feeling of effects on relationships, and 
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some use physical changes that lead to effects on sexual health. Most of the sexual 
dysfunction literature can be divided into two broad topics; psychological or 
physiological problems. 
With regard to the psychological effects of cervical cancer on a woman's sexual 
health, several problems are associated with cervical cancer survivors. Jensen et aI. 
(2004) found that 85% of patients, two years post-diagnosis, had no interest in sex. Then 
in 2007, Donovan et aI. found that cervical cancer survivors reported less interest in sex, 
more sexual dysfunction, and less satisfaction than women without cervical cancer. 
Furthermore, treatments, including surgery were associated with reduced sexual interest, 
feelings of negative body image, poor self-confidence, and anxiety about sexual 
performance. (Jensen et aI., 2004; Vrzackova, Weiss, & Cibula, 2010) 
The studies that have chosen to concentrate on the physical changes caused by 
cervical cancer have found several associations, particularly with treatment. For 
example, radiation therapy is associated with the physiological effects of stenosis and 
shortening of the vagina and reduced lubrication. (Abitbol & Davenport, 1974; Bodurka 
& Sun 2006; Donovan et al., 2007) Surgery is associated with anatomical effects such as 
reduced vaginal wall elasticity, vaginal shortening, and changes in hormone levels. 
(Vrzackova et aI., 2010) These physical changes have then been shown to cause the 
following problems: reduced sexual desire, dyspareunia (painful intercourse), and the loss 
of the ability to achieve orgasm, (Donovan et aI., 2007; Greenwald & McCorkle, 2008) 
2.2.1.1 Assessing the Impact of Diagnosis with the Sexual Adjustment Questionnaire 
(SAQ) 
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The Sexual Adjustment Questionnaire (SAQ) is a three section, 108-question 
instrument developed to assess the sexual health of cancer patients. One of its more 
interesting characteristics, noted by Greenwald and McCorkle (2008), is that the 
questionnaire seeks to distinguish between sexuality and sexual function. 
When the SAQ is utilized in cervical cancer research it is usually not used in its 
entirety. However, many of the studies that have evaluated sexual dysfunction using the 
SAQ, report the use of very similar questions. (Greenwald & McCorkle, 2008; Greimel et 
aI., 2009; Gotay, Farley, Kawamoto, & Mearig, 2008) In fact, the specific question that 
asks subjects to rate the effect of cancer on their sexual relationships is almost always 
asked. The results gathered by the questionnaire, however, are not always so consistent. 
Greenwald and McCorkle (2008) reported that stage of disease was associated 
with a negative effect on sexual relationships and that reduced frequency was associated 
with race. The same year Gotay et ai. (2008) found that 44% of the cervical cancer 
survivors sampled, reported cervical cancer had a negative impact on their sexual 
relationships. Alternatively, Griemel et ai. (2009) found no significant differences among 
study groups with regard to sexual activity, pleasure, or discomfort (frequency of sexual 
activity was found to be significantly less in survivors who were treated with surgery and 
radiation). 
2.2.2 Assessing Quality of Life with the MOS 36-item Short Form Survey (SF-36) 
The SF-36 is a validated survey tool designed to measure the quality of life of 
individuals regardless of age, disease, or treatment (higher scores indicate better quality 
of life). (Ware & Sherbourne, 1992) This tool, when used in cervical cancer research, 
evaluates many of the quality of life issues that have been reported by survivors, and has 
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been used when comparing study groups. Results have been inconsistent with some 
studies reporting negative impacts, some positive, and some no impact at all. (Gotay et 
aI., 2008; Bartoces et aI., 2009; Wenzel et aI., 2005; Frumovitz et aI., 2005; Greimel et 
aI.,2009) 
Several studies have evaluated quality of life among cervical cancer survivors 
using the SF-36 and have reported that they appear to have a better or similar quality of 
life in comparison to study groups. Gotay et aI. (2008) sought to investigate the 
differences in invasive cervical cancer survivors (who were also a part of the military 
health system) and a national normative sample formed from respondents to the National 
Health Survey of Functional Health Status and surveys conducted by the National 
Research Corporation. The researchers reported that cervical cancer survivors have better 
emotional well-being than comparative groups and that in general the cervical cancer 
survivors scored similar to the comparative groups in all of the SF-36 subscales. (Gotay 
et aI., 2008) In fact, in this study the only significant difference in quality of life measures 
was the increased mean for the mental health subscale score measured in cervical cancer 
survivors. (Gotayet aI., 2008) 
A similar result was found in the study by Bartoces et ai. (2009). In this study, 
designed to compare women with invasive and noninvasive cancer diagnoses, women in 
both groups were found to have similar SF-36 Mental and Physical Composite scores. 
Even after adjusting for demographic and medical information significant differences in 
mean scores were not found. (Bartoces et aI., 2009) 
Wenzel et aI. (2005) investigated the effects on long-term quality of life in 
cervical cancer survivors that were of child-bearing age. When cancer survivors (who 
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were diagnosed 5-10 years prior) were compared to age- matched controls no significant 
differences in quality of life were found between the groups. Specifically, when the 
difference in the mean SF-36 Mental and Physical Health Summary Scores of the cases 
and controls was compared it did not reach significance. (Wenzel et aI., 2005) In fact, 
survivors were to found to have a higher mean SF--36 Physical Health Summary score 
than the mean score seen in the normative data. (Wenzel et aI., 2005) 
Significant deficits in the quality of life of cervical cancer survivors have been 
reported as well. (Frumovitz et aI., 2005; Greimel et aI., 2009) In a study by Frumovitz et 
ai. (2005) researchers found that when survivors were grouped according to treatment, 
compared to each other, and also to a control group (using the SF-12, a subset of the SF-
36), significant differences were found. (Frumovitz et aI., 2005) In this study, women 
who were treated with radiation were found to have significantly lower mean physical 
component scores than women treated with only surgery and women in the control group. 
(Frumovitz et aI., 2005) 
Although the study by Greimel et ai. (2009) did not use the SF-36, significant 
quality of life differences between treatment groups were found. In this study, 
instruments similar to the SF-36, The European Organization for Research and Treatment 
of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC QLQ-C30) and the 
Cervix Cancer Module (QLQ-CX24) were used to assess the quality of life of 
participants. Researchers found that women treated with radiation were more likely to 
suffer from problems relating to physical functioning, role functioning, and cognitive and 
social functioning than surgical patients. (Greimel et aI., 2009) 
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The studies described in the above sections and their primary findings are briefly 
described in Appendix B. 
2.3 Covariates 
Many of the covariates used in the analysis were chosen because of their use in 
previous studies. Variables such as lifestyle factors (tobacco and alcohol use), age (age at 
diagnosis and current age), comorbidity, sexual history (number of sexual partners, age at 
first sexual contact), parity, spirituality, self-esteem, hormone replacement therapy, 
socioeconomic status, and survival time were previously identified in the literature 
surrounding cancer (all types and cervical cancer specific), sexual dysfunction, or quality 
of life. (See Appendix B) 
2.3.1 Depression 
Depression is a significant covariate in studies of sexual dysfunction. (Greenwald 
& McCorkle, 2008; Frumovitz et aI., 2005; Vistad et aI., 2006) The relationship between 
the outcome and covariate can be very complex and the direction of the relationships is 
not known. However, depression is commonly measured and used in analytical models 
as a control. 
2.3.1.1 Impact of Diagnosis with relation to the Center for Epidemiologic Studies-
Depression (CES-D) Scale 
The Center for Epidemiologic Studies Depression (CES-D) Scale is a commonly 
used tool in identifying depression among two study groups. This scale is a short survey 
designed to measure self-reported, depressive symptom levels. (Radloff, 1977) 
With regard to cervical cancer studies, the CES-D scale has been used often to 
evaluate depression in participants. For example, Greenwald and McCorkle (2008), 
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report the CES-D scale is used as a "correlate of sexual dysfunction." Although 
depression was not found to be associated with sexual dysfunction in this study, 47.1 % of 
the sample was scored as "depressed" using the CES-D scale. (Greenwald &McCorkle, 
2008) Interestingly, the large percentage of women who were determined to be 
depressed (using the CES-D scale) did not all report being depressed. Nearly 80% of the 





The Adaptation and Quality of Life among Long-Term Cervical Cancer Survivors 
study was a National Cancer Institute's Surveillance, Epidemiology, and End Results 
Program (SEER) special study conducted among several SEER sites in the country. The 
study was initially proposed to study the differences among cervical cancer survivors by 
stage of diagnosis and ethnicity. After completion, the study was intended to provide data 
on long-term survivors in a population where little to none was available. This thesis will 
focus on analysis of data collected for the New Mexico site. 
3.1 Study Description 
Cervical cancer cases were ascertained through the New Mexico Tumor Registry 
(NMTR). Women between the ages of 25 and 79, who were residents of New Mexico at 
the time of diagnosis, were of Hispanic or non-Hispanic white ethnicity, and had been 
diagnosed with carcinoma in situ or invasive cervical disease between the years 1980 and 
1999 were considered to be eligible to participate. A total of 2,016 cases met the 
eligibility criteria. Letters were sent to a subjects' diagnosing physician (if known) to 
confirm diagnosis; a total of 1,389 subjects had physicians listed on the NMTR. A 
refusal (from a physician) was received for only 2 subjects. Patient contact was then 
initiated for 1,612 potential participants. The patient correspondence included: letters 
that described the study and a study brochure. The brochure stated the study purpose and 
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goals, explained the questionnaire, and explained the function of the tumor registry. 
Subjects were then given 14 days to refuse participation or to clarify any details of the 
information that was sent, and also to attempt to learn which addresses were incorrect 
before the questionnaires were mailed. A total of 195 subjects were found to have 
incorrect contact information and 4 potential subjects refused to participate. Over a 
period of 19 months, 1,414 questionnaires were mailed to potential participants. They 
were given 2-4 weeks to complete and return the questionnaire; if this deadline was not 
met they were called in an attempt to complete the questionnaire by phone. Out of the 
questionnaires mailed to subjects, 150 were assumed to not have been received (143 were 
deemed to have incorrect contact information and seven were deceased) and 1,264 
questionnaires were assumed to have reached subjects. There were 197 completed 
questionnaires used for analysis (78 refusals and 989 unreturned). 
3.2 Data Collection 
The clinical data that was collected on subjects, such as diagnosis data, tumor 
characteristics, and initial treatment, were gathered from the NMTR. At the time of 
interview, and questionnaire administration, additional data was collected. The 
questionnaire used was a compilation of the scales of interest; SF-36, CES-D scale, 
Charlson Comorbidity Index, and Sexual Adjustment Questionnaire, as well as questions 
that provided the data for the covariates of interest. 
3.2.1 New Mexico Tumor Registry (NMTR) 
The NMTR was utilized in the QOL Cervical Cancer Survivors study to ascertain 
potential subjects. After potential subjects were ascertained, medical information such as 
diagnostics, histological information, and demographics was captured from the registry 
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and used to build the list of eligible participants. It was also used for the name and 
address of the diagnosing physician (when available). (Baumgartner, Fetherolf, Wheeler, 
Hunt, & Key, 2003) 
3.2.2 Questionnaire 
The New Mexico Community Health Survey, "Quality of Life and Cervical 
Disease" was the instrument created to collect patient data at the New Mexico Site. It is a 
combination of various sources and previously used questionnaires. It consists of four 
sections that record data on a variety of different variables such as diagnosis and 
treatment of cervical disease, comorbidity, psychological influences on disease, lifestyle 
information, and sexual history. 
3.2.3 MOS 36-item Short Form Survey (SF-36), Center for Epidemiologic Studies-
Depression (CES-D) Scale, and Charlson Comorbidity Index 
The SF-36, CES-D scale and the Charlson Comorbidity Index were used to 
measure the outcomes or covariates of interest used in this thesis. Each scale includes a 
series of questions that combine to form a composite score as described below. 
3.2.3.1 SF-36 
The SF-36 questionnaire is based on a set of 36 questions that captures data 
related to physical and emotional health. The questions are summarized into a set of 
eight scales (physical functioning, role-physical, bodily pain, general health, vitality, 
social functioning, role-emotional, and mental health) which are further summarized into 
two summary measures (physical health and mental health). The scores for the scales 
and summary measures range from 1-100, with higher scores indicating better quality of 
life. Differences in mean scores, of the eight subscales or the two summary measures, can 
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also be tabulated to indicate a difference in quality of life among two study groups. (Ware 
& Sherbourne, 1992) 
Several reports of the SF-36 reliability and validity have shown that it is highly 
reliable and that its tests of validity are inconsistent. Reliability tests date back to 1993 
and consistently measure reliability statistics above 0.70 (the minimum standard). (Tsai, 
Bayliss, & Ware, 1997) Several other studies have published reliability statistics that 
range from 0.80 to >0.90 depending on the scale or summary score being analyzed. 
(McHorney, Ware, Lu, & Sherbourne, 1994; Ware, Gandek, and the IQOLA Project 
Group, 1994) With regard to validity, out of the 10 measures, the most valid mental 
health measures are the Mental Health, Role Emotional, and Social Function scales, and 
the Mental Component summary measure. For physical measures, Physical Function, 
Role Physical, and Bodily Pain scales, and the Physical Component summary measure 
have been found to be most valid. (Ware, n.d.) 
For the portion of the analysis that dealt with the quality of life of the subjects, the 
summary measures for physical health and mental health were used. These outcome 
variables were analyzed continuously to determine whether other independent variables 
affected the mean score of physical and/or mental health. 
3.2.3.2 CES-D 
Depression was investigated using the CES-D scale. This scale was developed as 
a tool that measures level of depressive symptoms in a population-based study, where the 
scale would need to be short and answers would be self-reported. (Radloff, 1977) The 
scale is composed of 20 questions that are designed to detect depressive symptoms and 
adverse events that may be occurring in an individual's life. It has been validated as a 
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tool to detect depression in studies that compare depressed groups to the general 
population. Tests of reliability and validity yield reliability coefficients of 0.85 or more 
and validity correlations of 0.40 or more. (Radloff, 1977) 
The scores from the CES_D scale range from 0-60 with higher scores indicating 
an increased number of depressive symptoms. (Radloff, 1977) According to the original 
paper by Radloff (1977), a score of ~ 16 is indicative of depression. Therefore, during 
analysis subjects' CES_D scores were dichotomized as ~16 being considered to be 
depressed and < 16 being considered as not be depressed. 
3.2.3.3 Charlson Comorbidity Index 
The Charlson Comorbidity Index was developed to identify the risk of death due 
to comorbid conditions in longitudinal studies of hospitalized patients. (Charlson, 
Pompei, Ales, & MacKenzie, 1987) The approach is a weighted approach that takes into 
account the number of comorbid conditions as well as the severity of those conditions. 
(Charlson et aI., 1987) Since its development, it has been validated as a tool used in 
breast cancer research and it was also adapted to be used in combination with 
International Classification of Diseases, Ninth Revision (ICD-9) codes. (McGregor et aI., 
2005) 
Scores from the Charlson Comorbidity Index can be analyzed continuously from 
0-8 or categorically. When analyzed categorically, subjects' scores are placed into the 
following risk categories: no risk (0); low risk 0-2); moderate risk (3-4); and high risk 
(5-8). (Charlson et aI., 1987) When analyzing comorbidity as a possible covariate of 
sexual dysfunction or quality of life, the variable was left as a categorical variable using 
the cut-points described by the author. 
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3.2.4 Measures of Sexual Dysfunction 
Sexual dysfunction was measured in the questionnaire using the Sexual 
Adjustment Questionnaire. The SAQ is a 108-question tool developed to evaluate the 
effect of cancer on a patient's sexuality and sexual function. (Waterhouse & Metcalfe, 
1991; Greenwald & McCorkle, 2008) The questions are divided into three sections that 
correspond to relevant time-periods in a cancer patient's life: diagnosis, surgery, and 
convalescence. (Waterhouse & Metcalfe, 1986) 
Aside from measuring changes based on time, the SAQ also divides the subject's 
sexual health into sexuality (desire and importance of sex) and function (enjoyment, 
tension, or frustration). Sexuality and sexual function are similar, but separate dimensions 
of a sexual relationship. When studying sexual dysfunction, if sexuality and function are 
not measured carefully, associations between covariates and sexual functioning could be 
hard to determine. Therefore, separating the two is preferable. 
Lastly, the SAQ specifically evaluates the effect of a cancer diagnosis on the 
subject's sexual relationships. (Waterhouse & Metcalfe, 1986; Greenwald & McCorkle, 
2008) By asking respondents to rate the impact cancer has had on their sexual 
relationships researchers are able to measure a self-reported, quality of life difference 
caused by a cancer. 
The reliability of the SAQ has been found to range from 0.67 -1. (Greimel et aI., 
2009) The initial mean reliability for all three sections was found to be 0.67 by 
Waterhouse and Metcalfe (1986). However, according to Greenwald and McCorkle 
(2008) the SAQ exhibits high reliability and validity in its revised forms. The developers 
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of the questionnaire do cite validity as a problem in prostate and neck cancers. 
(Waterhouse & Metcalfe, 1986) 
Only a portion of the Sexual Adjustment Questionnaire (SAQ) was used in the 
QOL Cervical Cancer Study. Appendix C provides a listing of the SAQ questions 
included in this study. 
Due to the lack of a complete scale used to measure sexual dysfunction, a single 
question was chosen to be an indicator of the outcome. The question that asked subjects 
to rate the effect their cervical cancer diagnosis had on their sexual relationship was 
determined to measure the outcome best and was used as an indicator of sexual 
dysfunction. The responses to this question were dichotomized with "Very Bad Effect" 
and "Some Bad Effect" being pooled to indicate dysfunction, and "No effect," "Some 
Good Effect," and "Very Good Effect" pooled to indicate a lack of dysfunction. All 
subjects who reported "no partner" were excluded from analysis. 
The covariates age, menopausal status, physical activity, depression, comorbidity, 
BMI, socioeconomic class, tobacco use and alcohol consumption were also measured. 
For a complete listing of variables used see Appendix A. 
3.3 Statistical Plan 
The goal of this thesis is to determine if cervical cancer survivors differ in quality 
of life, sexual functioning and depression by type of diagnosis and treatment. The four a 
priori hypotheses are as follows: 
1. Women diagnosed with cervical cancer who are treated with radiation will report 
more sexual dysfunction than women receiving other forms of treatment (surgery 
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and chemotherapy), controlling for: age, menopausal status, physical activity, 
depression, comorbidity, BMI, and insurance status. 
2. Women diagnosed with invasive cervical cancer will be more likely to suffer from 
sexual dysfunction than those diagnosed with carcinoma in situ, controlling for; 
age, menopausal status, physical activity, depression, comorbidity, BMI, and 
insurance status. 
3. Women diagnosed with invasive cervical cancer will be more likely to be 
depressed as measured by the CES_D than the women diagnosed with carcinoma 
in situ, controlling for; comorbidity, smoking, alcohol consumption, fatigue, 
physical activity, BM!, SES and sexual dysfunction. 
4. Women who report more sexual dysfunction and depression will have a lower 
overall quality of life as measured by the SF-36 controlling for comorbidity, 
smoking, alcohol consumption, physical activity, BMI, and SES. 
Based on the secondary aim the hypothesis is as follows: 
1. Women who report they suffer from depression (when measured as 
comorbidity) will also be depressed based on the CES-D scale. 
3.3.1 Logistic Regression Models 
In order to evaluate the relationships between sexual dysfunction, radiation 
therapy, and stage of disease (hypotheses 1-3), a logistic regression model was created 
and analyzed using SAS version 9.3. Each model was initially adjusted for age, 
socioeconomic factors (ethnicity, income, and education), and the other covariates listed 
in each hypothesis. Radiation and stage of disease were analyzed as dichotomous 
variables (i.e., did or did not have radiation therapy, invasive or in situ disease). Each 
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covariate was categorized based on its distribution within the study population. Age and 
BMI were considered as both continuous and categorical variables throughout the model 
building process. 
3.3.2 Linear Regression Model 
In order to evaluate the relationship between quality of life, sexual dysfunction, 
and depression (hypothesis 4) a generalized linear model was created and analyzed using 
SAS version 9.3. This model was initially adjusted for age, socioeconomic status 
(ethnicity, income, and education), and the covariates listed in the hypothesis. 
As was described above, the SF-36 summary measures were analyzed 
co~tinuously. Sexual dysfunction and depression were analyzed as dichotomous variables 
using the same methods as the logistic regression models. BMI and age were considered 
as continuous and categorical variables to identify if there was a difference in the 
analysis. The remaining covariates listed in the hypothesis were initially analyzed using 
the categories set forth by the questionnaire. Changes were made to the categories 
through the model-building process. However, Table 4.14 and 4.16 depict the final 
models used for the SF-36 summary measures and the categorization (if any). 
3.4 Power 
There were two types of analyses completed in this thesis: logistic regression (for 
estimating odds ratios) and linear regression (for estimating correlations (R\ Since the 
data was previously collected, sample sizes were fixed. In order to evaluate statistical 
power estimates of the minimum detectable effect size were calculated based on the 
sample size and exposure frequencies for the type of analysis. These calculations were 
completed using the free online software, Open Epi (http://www.openepi.com ). 
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3.4.1 Logistic Regression Models 
Open Epi cites Schlesselman's sample size equation as the way in which the 
minimum detectable odds ratio in logistic regression models are estimated. 
(Schlesselman, 1982; Schlesselman, 1974) This standard equation estimates sample sizes 
in a case-control study given assumptions for exposure frequencies, statistical power (Zb), 
and significance level (Za). If the equation is rearranged, it can then be used to solve for 
effect sizes. Therefore, using Open Epi the minimum detectable effect estimate for 80% 
power can be determined. 
The number of subjects for the first two hypotheses (associations between sexual 
dysfunction and stage of disease and between sexual dysfunction and treatment) was very 
similar. Therefore, to evaluate power, data from the logistic model that analyzed the 
association between sexual dysfunction and stage of disease was used. In this model, 51 
women were considered to have sexual dysfunction (cases) and 115 women were 
considered to be without dysfunction (controls). Given these sample sizes, there is 80% 
power to consider (OR ~2.7) and be statistically significant (at p ~ 0.05). 
To determine the power involved in the logistic model for the third hypothesis 
(association between stage of disease and depression), 62 women were considered to be 
depressed (cases) and 129 women were considered to not be depressed (controls). Given 
these sample sizes, there is 80% power to consider OR ~2.5 to be significant (at p~ 0.05). 
3.4.2 Linear Regression Models 
Continuous data or interval scale data were utilized in the linear regression 
models to analyze hypothesis four (the association between sexual dysfunction and 
quality of life). These models were based on sample sizes that ranged from 156 to 163 
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subjects (depending on missing data). Using Cohen's tables, correlation coefficients 






4.1 Descriptive Characteristics of the Sample 
The mean age of the sample, at the time of interview, was 51 (SD 9.1) and the 
mean age of the sample, at diagnosis, was 41 (SD 9.2). Approximately 68% of the 
women were Non-Hispanic White women; 26% were Hispanic and 5% self-reported as 
"Other" ethnicity (Asian/Pacific Islander, American Indian/Alaska Native, Other). A 
majority of the women were married or cohabitating at time of diagnosis (70.1 %) and 
interview (66.5%). Approximately 33% of the women had some college or technical 
school at diagnosis (37.1 %) and at the time of interview (37%), and most had insurance 
(82.7%). Women who reported to have a current income of greater than $50,000 at the 
time of interview composed the biggest income level (29.4%). This was not the case at 
the time of diagnosis. At time of diagnosis, 24.9% of women reported to have an annual 
income of between $15,000 and $29,000. Table 4.1 presents these characteristics for the 
sample as well as the characteristics stratified by stage of disease. (There were no 
significant differences between in situ and invasive survivors based on demographic 
characteristics ). 
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4.1 Demograehic Characteristics o[Sameie by' Stage 
Variable All Invasive in situ Chi-Square/p 8 
Women (n=94) (n=101) 
No. % No. % No. % Chi-Square p 
Age, diagnosis <0.02 0.9 
<30 14 7.1 9 9.6 5 5 
30-39 81 41.1 35 37.2 45 44.6 
40-49 67 34 33 35.1 34 33.7 
50-59 27 13.7 12 12.8 14 13.9 
60-69 8 4.1 5 5.3 3 3 
N Age, current 3.8 0.5 
-.J 
<40 16 8.1 5 5.3 11 10.9 
40-49 71 36 33 35.1 37 36.6 
50-59 70 35.5 30 31.9 40 39.6 
>60 38 19.3 24 25.5 13 12.9 
Missing 2 2 2.1 
Marital Status, diagnosis 3.3 0.1 
Married or Cohabitating 138 70.1 71 75.5 65 64.4 
Not Married 58 29.4 22 23.4 36 35.6 
Missing 0.5 1.1 
Marital Status, current 0.7 0.4 
Married or Cohabitating 131 66.5 59 62.8 70 69.3 
Not Married 65 33 34 36.2 31 30.7 
Missing 0.5 0.5 
Education, diagnosis 3.3 0.1 
High school graduate or Less 67 34 38 40.4 28 27.7 
Some college or technical school 73 37.1 34 36.2 39 38.6 
College graduate 29 14.7 10 10.6 18 17.8 
Graduate school 26 13.2 11 11.7 15 14.9 
Missing 2 1.1 
tv Education, current 2.8 0.1 
00 
High school graduate or Less 47 24.1 27 28.7 20 19.8 
Some college or technical school 72 36.9 36 38.3 36 35.6 
College graduate 38 19.5 16 17 22 21.9 
Graduate school 32 16.4 13 13.8 19 18.8 
Missing 6 3.1 2 2.1 4 4 
Income, diagnosis 0.5 0.5 
<$14,999 47 23.9 27 28.7 19 18.8 
$15,000-$29,999 49 24.9 18 19.2 31 30.7 
$30,000-$39,999 36 18.3 20 21.3 15 14.9 
$50,000 or more 36 18.3 16 17 20 19.8 
UnknownlMissinglRefused 29 14.7 13 13.8 16 15.8 
Income, current 0.4 0.5 
<$14,999 32 16.2 15 16 16 15.8 
$15,000-$29,999 42 21.3 24 25.3 18 17.8 
$30,000-$39,999 36 18.3 17 18.1 19 18.8 
$50,000 or more 58 29.4 26 27.7 31 30.7 
U nknownlMissi ng/Refused 29 14.7 12 12.R 17 16.8 
Ethnicity 0.1 0.8 
Non-Hispanic, white 133 67.5 65 69.2 67 66.3 
tv Hispanic 51 25.9 20 21.3 30 30 
\0 
Other 10 5.1 6 6.4 4 4 
Missing 3 1.5 3 3.2 
Insurance, current 0.3 0.6 
Yes 163 82.7 78 83 83 82.2 
No 28 14.2 12 12.8 16 15.8 
Missing 6 3.1 4 4.3 2 2 
a. 
n=2 unstaged; excluded from analysis 
4.1.2 Behavioral and Physical Characteristics 
The mean, BMI (at the time of the interview) of the study population was 27.8 
(SD 6.6). The mean BMI at diagnosis was 25.0 (SD 6.4). Subjects were also categorized 
into three groups using the World Health Organization's BMI cut points for normal 
(18.5-24.99), overweight (25-29.99), and obese (~30) individuals. (World Health 
Organization, 2006) At diagnosis 53% of women had a BMI of <25 and at time of 
interview 37.1 % had a BMI of < 25. At the time of diagnosis most women were still 
having periods or were in menopause (81.2%). Then at the time of interview most 
women were no longer having periods or were post-menopausal (71.1 %). 
The majority of women reported to have participated in at least one form of 
physical activity in the past month (75.4%). A majority of subjects also reported to have 
had at least one alcoholic beverage in the past month (54.8%) and to have smoked at least 
100 cigarettes in their lifetime (58.9%). 
Table 4.2 shows the physical and behavioral characteristics of the sample. Most 
of characteristics did not any significant associations when compared by stage of cervical 
cancer. However, the women's menstrual status at the time of interview was found to be 
associated by stage, (X2 = 23.4 p <0.01). 
30 
Table 4.2 Phy,sical and Behavioral Characteristics o[Survivors by, Stage o[Cervical Cancer 
Variable All Invasive in situ Chi-Square/pa 
Women (n=94) (n=lOl) 
No. % No. % No. % Chi-Square p 
Menstrual Status, diagnosis 1.3 0.3 
Having periods or in menopause 160 81.2 75 79.8 83 82.2 
No longer having periods or post- 27 13.7 16 8.217 II 10.9 
menopausal 
Don't know or missing 10 5.1 3 3.2 7 6.9 
Menstrual Status, current 23.5 <0.01 
Having periods or in menopause 50 25.4 9 9.6 39 38.6 
VJ No longer having periods or post- 140 71.1 83 88.3 57 56.4 
menopausal 
Don't know or missing 7 3.6 2 2.1 5 5 
Physical Activity 0.3 0.6 
Physical activity, past month 147 75.4 68 72.3 79 78.2 
No physical activity, past month 45 23.1 23 24.5 22 21.9 
Missing or Refused 3 1.5 3 3.2 
BMI, diagnosis 0.2 0.6 
Less than 25 105 53.3 53 56.4 50 49.5 
25-29 35 17.8 16 17 19 18.8 
30 or more 25 12.7 12 12.8 13 12.9 
Missing 32 16.2 13 13.8 19 18.8 
BMI, current <0.01 1.0 
Less than 25 73 37.1 35 37.2 37 36.6 
25-29 58 29.4 27 28.7 30 29.7 
30 or more 59 30 29 49.2 30 29.7 
Missing 7 3.6 3 3.2 4 4 
Alcohol Consumption 0.4 0.6 
I +, past month 108 54.8 50 53.2 58 57.4 
None, past month 87 44.2 43 45.7 42 41.6 
Missing 2 1.0 1.1 
VJ 
N 
Smoking status, lifetime 0.2 0.7 
Ever Smoked 116 58.9 57 60.6 59 58.4 
Never Smoked 80 40.6 36 38.3 42 41.6 
Missing 0.5 1.1 
Smoking status, current 2.4 0.1 
Smoke every day 43 21.8 26 27.7 17 16.8 
Smoke some days 9 4.6 3 3.2 6 5.9 
Never smoked 63 32 28 29.8 35 34.7 
Missing 82 42 37 39.4 43 42.6 
an=2 unstaged; excluded from analysis 
4.1.3 Other Co variates of Interest 
Data collected on treatment options described 91 % percent of the sample as 
having had some form of surgery to treat their disease, 15 % of the subjects having 
received radiation therapy, and 2% of the sample received chemotherapy for their cancer. 
When the treatment forms were compared by stage of disease, radiation therapy was 
found to be significantly associated (X2=36.84 p <.01). Table 4.3 represents the forms of 
treatment for all subjects as well as treatment stratified by stage of cervical cancer. 
Table 4.3 Treatment Oetions bI Stage ot Cervical Cancer 
Variable All Invasive in situ Chi-Square/pa 
Women (n=94) (n=lOl) 
No. % No. % No. % Chi-Square p 
Surgery 2.9 0.1 
Yes 180 91.4 83 88.3 96 95 
NOb 17 8.6 11 11.7 5 5 
Missing 
Radiation 36.8 <0.01 
No Radiation 166 84.3 64 68.1 101 100 
Radiation given 30 15.2 29 30.9 
Missing/U nknown 0.5 0.5 
Chemotherapy 4.4 0.05 
No Chemotherapy 192 97.5 89 94.7 101 100 
Chemotherapy" 4 2 4 4.3 
MissinglRefused 0.5 l.l 
a 
n=2 un staged; excluded from analysis 
bNo surgery based on surgery not recommended as 1 sl course treatment (n=3) or surgery recommended but not as 1 sl 
course treatment (n=14) 
CSingle or multiple agents 
The majority of women with data on comorbidity were scored as zero or "No 
Risk" by the Charlson Comorbidity Index (67.5%). Table 4.4 shows the distribution of 
the sample with regard to the Charlson Comorbidity Index as well as the index stratified 
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by stage of cervical cancer. There was not a significant difference between the two 
stages. 
Table 4.4 Charlson Comorbiditl. Index by' Stage 
Variable All Invasive in situ Chi-Square/pa 
Women (n=94) (n=lOl) 
No. % No. % No. % Chi-Square p 
Charlson Comorbidity 2.5 0.1 
Index 
No Risk (0) 133 67.5 61 64.9 71 70.3 
Low Risk (1-2) 48 24.4 23 24.5 24 24 
Moderate Risk (3-4) 4 2. 3 3.2 
High Risk (5-8) 5 2.5 4 4.3 
Missing 7 3.6 3 3.2 4 4 
'n=2 unstaged; excluded from analysis 
Subjects were also asked to rate their quality of life at two different time periods: 
2 years post-diagnosis and at the time of the interview. Many of the women responded 
that their quality of life was "Excellent" two years post-diagnosis (33.5%) and at the time 
of the interview (33%). A significant association was found when the survivors were 
stratified by stage (X2 = 9.2 p <0.01). Table 4.5 represents the responses to the self-
reported quality of life questions as well as those responses stratified by stage. 
Table 4.5 Self:Re1!.orted Qualitl. oiLiie by' Stage oi Cervical Cancer 
Variable All Invasive in situ Chi-Square/pD 
Women (n=94) (n=IOI) 
No. % No. % No. % Chi-Square p 
Self-reported QOL, 9.2 <0.01 
2 years post-
diagnosis 
Excellent 66 33.5 24 25.5 42 41.6 
Very Good 54 27.4 24 25.5 29 28.7 
Good 51 25.9 28 29.8 22 21.8 
FairlPoor 23 11.7 16 17 7 6.9 
Missing 3 1.5 2 2 
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Self-reported QOL, 2.6 0.1 
current 
ExceIlent 65 33 25 26.6 40 39.6 
Very Good 58 29.4 31 33 26 25.7 
Good 40 20.3 17 18.1 22 21.8 
FairlPoor 30 15.2 18 19.2 12 11.9 
Missing 4 2 3 3.2 
a n=2 unstaged; excluded from analysis 
4.1.4 Outcome Variables 
Depression, as measured by the CES-D scale, was found to occur in 32% of the 
sample when dichotomized ("depressed" (~16) and "not depressed" «16)). No 
significant differences were found when comparing in situ and invasive groups. See 
Table 4.6 for the distribution of depression in the sample and among in situ and invasive 
groups. 
Table 4.6 Subjects CES-D Scores by Stage 
Variable All Invasive in situ Chi-Square/p 3 
Women (n=94) (n=I01) 
No. % No. % No. % Chi-Square p 
CES-D Scale 0.1 0.7 
Score of <16 130 66 61 64.9 68 67.3 
Score of ~16 63 32 31 33 31 30.7 
Missing 4 2 2 2.1 2 2 
a 
n=2 unstaged; excluded from analysis 
With regard to the sexual history questions answered in the questionnaire, very 
few responses were missing from the dataset. However, many women indicated there 
was "No Sexual Activity" or "Partner" in their life. For the 8 questions, percentages for 
"no partner" or "no sexual activity" ranged from a minimum of 14.7%-26% and subjects 
were excluded from the analysis. 
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The majority of women (91 %) indicated they had an overall positive or negative 
sexual history among all the sexual history questions. Fifty-sex percent of women 
responded to all 8 sexual history questions with negative responses (i.e. Sex is "of no 
importance" or only "slightly important" or desire for sexual activity "Never" or "Almost 
Never"). Appendix C represents the frequencies of the responses to all 8 sexual history 
questions and the frequencies of the composite variable. 
The responses to the sexual dysfunction indicator (n=166) showed that many 
women felt their diagnosis had no effect on their sexual relationship with their partner 
(58.4%). However, only approximately 9% felt it had a positive effect ("some good" or 
"very good" effect), and approximately 26% felt it had a negative effect ("very bad" or 
"some bad" effect). Table 4.7 represents the distribution for the subjects' responses to 
the sexual dysfunction indicator as well as the indicator stratified by stage of disease. 
Table 4.7 Effect of Cervical Cancer on Sexual Relationship by Stage 
Variable All Invasive in situ Chi-Square/p 8 
Women (n=94) (n=lOl) 
No. % No. % No. % Chi-Square p 
Effect on 12.7 <0.01 
Sexual Relationship 
Very Bad/ 51 25.9 34 36.2 16 15.8 
Some Bad effect 
No effect/Some 115 58.4 43 45.7 71 70.3 
Good/ 
Good Effect 
Missing or No 31 15.7 17 18.1 14 13.9 
Eartner 
'n=2 unstaged; excluded from analysis 
The range of scores for the SF-36 Physical and Mental Health Summary Scores 
was 2-100. The mean Physical Health Summary Score of the sample (n=192) was 74.01 
(SD 22.4) and the mean Mental Health Summary Score was 68.80 (SD 21.8) 
4.1.4.1 Secondary Aim 
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The concordance between self-reported depression (measured by the Charlson 
Comorbidity Index) and depression (measured by the CES-D scale) was found to be 
significant (X2=27.5, p<O.Ol). 
4.2 Sexual Dysfunction, Stage of Disease, and Radiation Therapy 
Univariate analysis was used to evaluate if any variables were significantly 
associated with sexual dysfunction (Table 4.8). Radiation therapy, stage of disease, and 
depression were significant at the (p<O.05) level. All other covariates were not 
significant. 
Table 4.8 Univariate Models Describing the Effects on Sexual Dysfunction3 
Variable Name Odds Ratio Beta p n 
Stage 
················h· ... 
Depression 3.3 1.2 <0.01 166 
Age, currentC 0.9 165 
Age, 0.8 166 
Ethnicity 164 
Other 0.9 0.2 
Hispanic 0.9 -0.1 0.8 
White, 
Education, current 163 
HS graduate or less 1.5 0.4 0.5 
Some college 1.7 0.5 0.3 
College graduate 0.9 -0.1 0.9 
Graduate 
Education, diagnosis 
HS graduate or less 0.3 0.6 
Some college 0.4 0.5 
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College graduate 0.7 0.6 
Graduate 
Income, current 144 
<$10,000-$14,999 2.3 0.8 0.1 
$15,000-$29,999 0.9 -0.02 
$30,000-$39,999 1.6 0.5 0.3 
>$50,000" .. 
Income, 144 
<$10,000-$14,999 2.4 0.9 0.1 
$15,000-$29,999d 
$30,000-$39,999 1.9 0.6 0.2 
>$50,000 1.6 0.4 0.4 
Charlson Comorbidity 164 
High Risk 3.7 1.3 0.7 
Moderate Risk 2 0.9 
Low Risk -0.1 0.8 
No Riskd 
BMI, <-0.01 162 
BMI, 0.02 0.5 146 
Physical Activity 1.5 0.4 0.4 164 
Marital Status, current 1.9 0.6 0.1 
Marital Status, diagnosis 0.5 -0.8 
and referent groups for dichotomous variables can be found A 
bDepression as measured by the CES-D Scale. Scores of> 16 are indicative of depressive symptoms. 
cMeasured continuously 
dReferent Group 
eThe Charlson Comorbidity risk groups are defined based on the scores received. A score no risk (0), low 
risk (1-2), moderate risk (3-4), and high risk (5-8) 
It is important to note that the four hypotheses outlined in the statistical plan were 
determined prior to analysis of the data. Following data analysis, all subjects that were 
treated with radiation therapy were found to have invasive disease. (Table 4.3) Therefore, 
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stage of disease and treatment were proxies for one another and hypothesis 1 and 2 did 
not measure separate associations. 
When analyzing the relationship between treatment and sexual dysfunction, 
radiation therapy was significantly associated with sexual dysfunction (OR=3.6, 95% CI 
[1.4-9.3]) and depression was also found to be significantly associated. Age, 
socioeconomic factors (ethnicity, education, and income), physical characteristics, and 
behavioral characteristics were added to the model, one by one, to determine if there were 
significant associations. Depression, stage of disease, and radiation were the only 
consistently significant variables. In addition to models that only included significant 
variables, models that included variables that were found to be nearly significant during 
univariate analysis, and models defined by socioeconomic class and Physical and 
Behavioral characteristics were also constructed. The final model used to analyze the 
relationship between treatment and sexual dysfunction included the variables treatment 
and depression. Table 4.9 represents examples of models used to investigate the treatment 
and sexual dysfunction relationship. 
When investigating the relationship between stage of disease and sexual 
dysfunction, stage was significantly associated with sexual dysfunction (OR=3.7, 95% CI 
[1.8-7.6]). The only significant covariate was depression. Age, socioeconomic factors, 
physical characteristics, and behavioral characteristics were not significantly associated 
with sexual dysfunction or were confounders of the relationship between sexual 
dysfunction and stage. 
Models were built by adding covariates one by one until all variables listed in the 
statistical plan had been added. Again, when the model included all variables significant 
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associations with covariates (with the exception of depression) were not found. 
Alternative models were created based on socioeconomic status and physical and 
behavioral characteristics as well, but again only depression and stage of disease were 
significantly associated. Tables 4.10 represent examples of models used to investigate the 
relationship between sexual dysfunction, radiation, and stage. 
In models where radiation therapy was investigated as a predictor for sexual 
dysfunction, adjustment for stage reduced the effect estimate and radiation was no longer 
significant (OR=1.9, 95% CI [0.7-5.3]). Although stage was a confounder for the 
association of radiation with sexual dysfunction, this was not the case when evaluating 
the effect of stage. In a model where stage was the independent variable, adjustment for 
radiation did not attenuate the association (OR= 2.9,95% CI [1.5-7.1]). This is because 
all women who had radiation treatment were diagnosed with invasive disease, but not all 
women with invasive disease received radiation therapy. Therefore, it was not possible to 
evaluate treatment therapy and only sexual dysfunction's association with stage of 
disease could be evaluated. Lastly, depression was found to be an independent predictor 
of sexual dysfunction. 
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Table 4.9 Models Used to Describe the Effect of Radiation Therapy on Sexual Dysfunction 
Model n Covariates Parameter p Odds CI 
Estimates (Parameter Ratio 
Estimates) 
Adjusting for Socioeconomic 159 3.9 1.4-11.4 
Factors 
Age, currenta -0.01 0.01 
Depressionb 1.2 <0.01 
Ethnicity 
White, Non-Hispanicc - -
Hispanic -0.3 0.5 
Other 0.6 0.5 
Education, current 
High School Graduate or 0.1 0.9 
~ Less 
-
Some College 0.4 0.5 
Co lIege Graduate 0.2 0.8 
Graduate Schoolc - -
Adjusting for Physical or 157 3.4 1.1-9.8 
Behavioral Characteristics 
Depressionb 1.3 <0.01 
BMI, currenta -0.04 0.2 
Physical Activity 0.4 0.5 
Charlson Comorbidity Indexd 
No Riskc - -
Low Risk -0.7 0.2 
Moderate Risk 12.8 1 
High Risk 0.3 0.8 
Marital Status, current 0.7 0.1 
Adjusting for Depression and 163 1.9 0.7-5.3 
Stage 
Depressionb 1.2 <0.01 
+:>. 
N 
Stagee 1.1 <0.01 
Final Model: Adjusting for 165 
Depression 
Depression b 1.2 <0.01 
aMeasured continuously 
b Depression as measured by the CES-D Scale. Scores of>16 are indicative of depressive symptoms 
cReferent Group 
3.6 1.4-9.3 
dThe Charlson Comorbidity risk groups are defined based on the scores received. The groups were categorized as follows high risk (5-8), moderate risk (3-4), 
low risk (1-2), and no risk (0). 
eStage is modeled as a dichotomous variable with in situ and invasive cancer categories. The in situ group is used as the referent group 
.j:::. 
w 
Table 4.10 Models Used to Describe the Effect of Staee of Cervical Cancer on Sexual Dvsfunction 
Model n Covariates Parameter p Odds 
Estimates (Parameter Ratio 
Estimates) 
Adjusting for Socioeconomic 158 3.5 
Factors 
Age, current" -0.01 0.7 
Depressionb 1.2 <0.01 
Ethnicity 
White, Non-Hispanicc - -
Hispanic -0.1 0.8 
Other 0.6 0.4 
Education, current 
High School Graduate or -0.2 0.7 
Less 
Some College 0.1 0.8 
College Graduate -0.1 0.9 
Graduate Schoof - -
Adjusting for Physical or Behavioral 156 3.2 
Characteristics 
Depressionb 1.3 <0.01 
BMI, current" -0.03 0.3 
Physical Activity 0.4 0.4 
Charlson Comorbidity Indexd 
No Riske 
- -
Low Risk -0.8 0.1 
Moderate Risk 15.2 I 
High Risk -0.2 0.9 
Marital Status, current 0.7 0.1 
Adjusting for Depression and 163 2.9 
Radiation 






Radiatione 0.6 0.2 
Final Model: Adjusting for 164 3.7 1.8-7.6 
Depression 
Depressionb I.2 <0.01 
aMeasured continuously 
bDepression as measured by the CES-D Scale. Modeled as a dichotomous variable with the "depressed" group having scores of ~ 16 and the "not depressed" 
group having scores of <16. The "not depressed" group was considered to be the referent group 
cReferent Group 
dThe Charlson Comorbidity risk groups are defined based on the scores received. The groups were categorized as follows high risk (5-8), moderate risk (3-4), 
low risk (1-2), and no risk (0). 
eRadiation is modeled as a dichotomous variable "radiation" and "no radiation" categories. The "no radiation" group is used as the referent group. 
4.3 Depression and Stage 
Stage of disease was not found to be a significant predictor of depression. In 
univariate analyses several covariates were found to be significantly associated with 
depression. However, the only variable that remained significant throughout model-
building in multivariate analysis was self-reported QOL at the time of the interview. 
Model building was completed in a stepwise fashion to start and alternative models were 
created subsequently (i.e. models based on physical or behavior characteristics, 
socioeconomic class) In the final model, controlling only for self-reported QOL, stage 
was still not found to be a significant predictor of depression, (OR 0.995% CI [0.5-1.8]). 
Table 4.11 represents the univariate effects on depression. Table 4.12 represents 
examples of some of the models used to investigate the relationship between depression 
and stage. 
Table 4.11 Univariate Models Describing the Effects on Dee.ressionU,b 
Variable Name Odds Ratio Beta p n 
Stage 1.1 0.1 0.7 191 
Sexual Dysfunction 3.3 l.2 <0.01 166 
Age, <0.01 0.7 192 
Ag~:di~g~~;i;C 0.02 0.4 193 
Ethnicity 191 
Other l.6 0.5 0.5 
Hispanic 1.4 0.3 0.4 
White, Non-Hispanicd 
Education, current 192 
HS graduate or less 2.8 0.1 
Some college 2.4 0.9 0.1 
College graduate 0.5 -0.8 0.3 
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Graduate schoold 
Education, diagnosis 189 
HS graduate or less 2.8 0.05 
Some college 2.2 0.8 0.1 
College graduate 0.5 -0.7 0.3 
Graduate schoold 
Income, current 166 
<$10,000-$14,999 4 104 <0.01 
$15,000-$29,999 304 1.2 <0.01 
$30,000-$39,999 2.7 0.04 
>$50,000d 0 0 0 
Income, diagnosis 166 
<$10,000-$14,999 2.5 0.9 0.1 
$15,000-$29,999 1.9 0.2 
$30,000-$39,999 1.5 004 
>$50,000d 
Insurance Status 2.5 0.03 188 
Charlson Comorbidity 189 
High Risk lOA 2.3 0.04 
Moderate Risk 2.6 004 
Low Risk 1.8 0.6 0.1 
No Riskd 
BMI, 1.1 0.1 0.04 189 
BMI, 1.1 0.1 0.05 165 
Physical Activity 1.8 0.6 0.1 191 
Marital Status, current 1.7 0.5 0.1 193 
Marital Status, diagnosis 1.1 0.1 0.7 193 
Smoking Habits 1.2 0.2 0.5 193 
Drinking Habits 0.8 -0.2 0.5 192 
Menstrual Status, current -0.01 188 
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Menstrual Status, diagnosis 

























'Depression as measured by the CES-D Scale. Scores of> 16 are indicative of depressive symptoms 
bCoding and referent groups for dichotomous variables can be found in Appendix A 
cMeasured continuously 
dReferent Group 
e The Charlson Comorbidity risk groups are defined based on the scores received. The groups were 







Table 4.12 Models Used to Describe the Effect of Stage of Cervical Cancer on Depression 
Model n Covariates 

















Adjusting for Physical and Behavioral 180 
Characteristics 
BMI, current" 
Physical activity, past month 

























































Final Model: Adjusting for self-reported 
QOL 



















cThe Charlson Comorbidity Index risk groups are defined based on the scores received. The groups were categorized as follows high risk (5-8), moderate risk 
(3-4), low risk (1-2), and no risk (0). 
4.4 MOS 36-item Short Form Survey (SF -36) Physical and Mental Health Summary 
Scores 
4.4.1 Physical Health Summary Score, Depression, and Sexual Dysfunction 
During univariate analysis, several variables were significantly associated with a 
difference in the mean SF-36 physical health summary score, including the variables for 
depression and sexual dysfunction. During model building all significant variables found 
during univariate analysis were added one by one to a multivariate model. Alternatively, 
models based on socioeconomic factors and physical and behavioral characteristics were 
also created. The final model created accounted for approximately 43% of the variance, 
and included the following variables: depression, sexual dysfunction, BMI at the time of 
interview, the Charlson Comorbidity Index, and alcohol use. 
According to the results, depression results in a 16 point decrease (p <0.01) in the 
physical health score. Sexual dysfunction accounts for a 6-point decrease (p=0.03) in the 
physical health score, BMI decreases the score by 0.5 (p=0.0l), and alcohol use increases 
the score by 6 points (p=0.02). Lastly, being classified as "high or moderate risk" on the 
Charlson Comorbidity Index decreases the physical health score by 23 points (p < 0.01), 
and being classified as "low risk" decreases the score by 7 points (p=0.02). Table 4.13 
details the effects on the SF-36 Physical Health Summary Score during univariate 
analysis. Table 4.14 details examples of models that included variables based on 
socioeconomic factors or physical and behavioral characteristics. 
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Table 4.13 Univariate Models Describing the Effect on the SF-36 Physical Health Summary Scorea 
Variable Beta p n 
Sexual Dysfunction 0.1 -12.3 <0.01 189 
Age, 0.1 -0. <0.01 
Ag~,di~g~~;i;c . 0.03 -0.5 0.01 
Ethnicity 0.01 
Other -9.1 0.2 
Hispanic -0.7 0.9 
White, Non-Hispanicd 
Education, current 0.1 185 
HS graduate or less -16.2 <0.01 
Some college -10.7 0.02 
College graduate -3.8 0.5 
Graduate schoo1d 
Education, diagnosis 0.1 189 
8th grade or less -31.6 <0.01 
Some HS/ HS graduate -15.2 <0.01 
Some college -6.2 0.1 
College Grad/Graduate schoold 
Income, current 0.2 164 
<$10,000 -25.3 <0.01 
$10,000-$19,999 -13.5 0.01 
>$20,000d 
Income, diagnosis 0.2 164 
<$10,000 -24.6 <0.01 
$10,000-$14,999 -9.2 0.1 
$15,000-$19,999 -16.9 <0.01 
$20,000-$29,999 0.9 0.9 
$30,000-$39,999 -2.5 0.6 
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>$50,000d 
Insurance Status -1.1 0.8 
High Risk -36.6 <0.01 
Moderate Risk -37.6 <0.01 
Low Risk -16.4 <0.01 
No Riskd 
BMI, ~.,.~o~,t' 0.1 -0.8 <0.01 
BMI, UIa.t;IR""" -1.4 <0.01 
Smoking Habits -7.2 0.03 
Drinking Habits 0.1 10.8 <0.01 
Physical Activity <0.01 
and groups can be in A 
bDepression as measured by the CES-D Scale. Scores of> 16 are indicative of depressive symptoms 
cMeasured continuously 
dReferent Group 
eThe Charlson Comorbidity risk groups are defined based on the scores received. The groups were 











Table 4.14 Models Describing the Effect on Cervical Cancer Survivor's SF-36 Phvsical Health Score 
Model n Covariates Parameter p 
Estimates (Parameter 
Estimates) 
Socioeconomic Factors, Depression and Sexual Dysfunctiona 139 
Age, current -0.4 0.04 
Depressionb -15.9 <0.01 
Sexual DysfunctionC -5.6 0.01 
Education, current 
High school graduate or less -3.3 0.5 
Some college -5.9 0.2 
College graduate -2.2 0.7 
Graduate Schoold - -
Income, current 
<$10,000 -12.9 0.02 
$10,001-$19,999 -6.7 0.2 
$20,000 +d - -
Physical and Behavioral Characteristics, Depression and 154 
Sexual Dysfunctiona 
Age, current -0.3 0.1 
Depressionb -16 <0.01 
Sexual DysfunctionC -5.7 0.05 
BMI, current" -0.5 0.01 
Charlson Comorbidity Indexf 
HighlModerate Risk -22 <0.01 
Low Risk -5.2 0.1 
No Riskd - -
Alcohol Use 5.6 0.03 
Physical Activity, past month -3.7 0.3 








Depressionb -15.7 <0.01 
Sexual DysfunctionC -6.1 0.03 
BMI, current" -0.5 0.01 
Charlson Comorbidity Index f 
High/Moderate Risk -23.1 <0.01 
Low Risk -7.3 0.02 
No Riskd 
Alcohol Use 5.9 0.02 
aVariables were chosen based on the p-values seen in univariate models 
bDepression as measured by the CES-D scale. Scores were dichotomized with <16 being the "not depressed" referent group and 2:16 being the "depressed" 
group 
cSexual dysfunction as measured by the survivor's answer to the question: "What effect has your diagnosis of cervical cancer/disease had on your sexual 
relationship with your partner?" The responses were dichotomized into two groups, "no effect/some good/very good effect" (referent group) and "Very 
bad/some bad effect" 
dRefercnt Group 
eMeasured continuously 
fThe Charlson Comorbidity risk groups are defined based on the scores received. A score of 0= no risk, 1-2=low risk, 3-4=moderate risk, and 5-8=high risk. 
Categories were further coI\apsed into 3 groups: 0 (no risk), 1-2 (Low risk), and 3-8 (moderate/high risk). 
4.4.2 Mental Health Summary Score, Depression, and Sexual Dysfunction 
The SF-36 Mental Health Summary Score was significantly associated with 
several covariates during univariate analysis, including depression and sexual 
dysfunction. During model building all significant variables found during univariate 
analysis were added one by one to the multivariate model. However, when all significant 
variables were modeled together, depression and sexual dysfunction were the only 
variables that were significant (p <0.05 level). Additionally, models based on 
socioeconomic factors and behavioral and physical characteristics were constructed. The 
final model included only depression and sexual dysfunction (both significant at the 
(p<0.05) level). 
Depression and sexual dysfunction accounted for 45% of the variance. 
Depression decreases the mental health score by 28 points (p <0.01) and sexual 
dysfunction decreases the score by 7 points (p=0.01). Table 4.15 details the effects on 
the mental health summary score using univariate models and Table 4.16 represents 
examples of the multivariate models used. 
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Table 4.15 Univariate Models Describing the Effect on the SF-36 Mental Health Summary Scorea 
Variable Name Beta p n 
Sexual Dysfunction 0.1 -14.1 <0.01 162 
Age, <0.01 -0.1 0.4 189 
Age, 0.01 -0.3 0.1 189 
Ethnicity <0.01 188 
Other -7.8 0.3 
Hispanic -3.4 0.4 
White, Non-Hispanicd 
Education, current 0.03 185 
HS graduate or less -9 0.1 
Some college -6.1 0.2 
College graduate -1.2 0.8 
Graduate schoold 
Education, diagnosis 0.04 189 
8th grade or less -13.6 0.2 
Some HS or HS graduate -9.9 0.01 
Some college -5.9 0.1 
College Grad/Graduate schoold 
Income, current 164 
<$10,000 -20.1 <0.01 
$10,000-$19,999 -11.8 0.02 
>$20,000d 
Income, diagnosis 0.1 164 
<$10,000-$14,999 -16 <0.01 
$15,000-$19,999 -21.5 <0.01 
$20,000-$39,999 -4.5 0.3 
>$50,00d 
Insurance Status <0.01 -3.7 0.4 185 
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High Risk -50.6 <0.01 
Moderate Risk -16.6 0.1 




BMI, ,.uUS''''~'~ -0.8 <0.01 
Smoking Habits -3.4 0.3 
Drinking Habits 0.01 4.49 0.2 
Physical Activity 0.1 13.2 <0.01 
and referent groups for dichotomous variables can be in A 
bDepression as measured by the CES-D Scale. Scores of> 16 are indicative of depressive symptoms 
cMeasured continuously 
dReferent Group 
"The Charlson Comorbidity risk groups are defined based on the scores received. The groups were 










Table 4.16 Models Describing the Effects on Cervical Cancer Survivor's SF-36 Mental Health Summary Score 
Model n Covariates Parameter p R2 
Estimates (Parameter 
Estimates) 
All variables with significant estimates during 135 0.5 
univariate analysis 
Depression" -26.8 <0.01 
Sexual Dysfunctionb -4.9 0.01 
Education, diagnosis 
8th grade or less 12.9 0.5 
Some high schoollhigh 0.5 0.9 
school graduate 
Some college 0.4 0.9 
College graduate/graduate - -
Schoolc 
Income, current 
<$10,000 -2.3 0.7 
$ 10,001-$19,999 -5.7 0.2 
$20.000 +c - -
Charlson Comorbidity Indexd 
HighIModerate Risk -18.4 0.01 
Low Risk -2.3 0.5 
No Riskc - -
Physical Activity, past month -4.1 0.2 
BMI, current" 0.01 I 
Depression, sexual dysfunction, and the 160 0.5 
Charlson Comorbidity Index 
Depression" -25.6 <0.01 
Sexual Dysfunctionb -6.3 0.02 
Charlson Comorbidity Indexd 
HighIModerate Risk -19.9 <0.01 




Final Model 162 0.5 
Depression" -27.8 <0.01 
Sexual Dysfunctionb -6.9 0.01 
- - -
"Depression as measured by the CES-D scale. Scores were dichotomized with < 16 being the "not depressed" referent group and ~ 16 being the "depressed" group 
bSexual dysfunction as measured by the survivor's answer to the question: "What effect has your diagnosis of cervical cancer/disease had on your sexual 
relationship with your partner?" The responses were dichotomized into two groups, "no effect/some good/very good effect" (referent group) and "Very 
bad/some bad effect" 
cReferent Group 
dThe Charlson Comorbidity risk groups are defmed based on the scores received. The groups were categorized as follows high risk (5-8), moderate risk (3-4), 




The analysis conducted in this study found that stage of disease was a predictor of 
sexual dysfunction, radiation was a predictor of sexual dysfunction, depression was a 
predictor of sexual dysfunction independent of stage and treatment, and that depression 
and sexual dysfunction cause a decrease in the quality of Life (QOL) of survivors (as 
measured by the SF36 Physical and Mental Health Summary Scores). These findings 
parallel the findings in the literature surrounding cervical cancer quality of life. Most 
researchers have found that cervical cancer negatively affects the women's sexual 
relationships, mental health, and/or their overall quality of life. 
5.1 Associations with Sexual Dysfunction 
The SAQ was used to determine what aspects of life, which are common to 
cervical cancer survivors, might be associated with a higher risk of sexual dysfunction. 
In the literature, when the SAQ was utilized to measure sexual dysfunction, cancer 
survivors were found to have more problems surrounding sexual health than in 
comparison groups. (Gotay et aI., 2008; Greimel et aI., 2009) Although the data analyzed 
in this thesis found a slightly smaller frequency than Greenwald and McCorkle (2008) 
found, at least 25% of the women cited cervical cancer as causing problems in their 
sexual relationships. 
5.1.1 The a priori Hypotheses 
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Two a priori hypotheses investigated the association between stage and sexual 
dysfunction and treatment and sexual dysfunction. However, when data analysis was 
completed the two hypotheses were found to be proxies of each other. The study sample 
was composed of a radiation therapy group that did not include both invasive and in situ 
cases. Only invasive cases composed the radiation group. Therefore, it was not possible 
to separate the effects of treatment from stage of disease on sexual dysfunction. 
The majority of the literature focuses on treatment with regard to sexual 
dysfunction and not stage of disease. This is logical because as the stage of disease 
increases, so too does the probability of radiation therapy. And, even though strong 
associations exist between stage, sexual dysfunction, and treatment the true source of the 
dysfunction has not been identified. However, radiation therapy is often reported to be 
associated with negative effects on sexual function. 
Frumovitz et aI. (2005) found that patients who received radiation therapy as a 
form of treatment were diagnosed with a more advanced stage of disease. Additionally, 
studies that use treatment as the independent variable, especially treatment with radiation 
therapy, have found strong associations with poor sexual health. Radiation has been 
associated with significantly worse sexual dysfunction when compared to surgical forms 
of treatment, and has been associated with an increased number of anatomical changes 
that lead to dysfunction, (Frumovitz et aI., 2005; Donovan et al., 2007; Bodurka et aI., 
2006) 
5.1.2 Focusing on the Relationship Between Sexual Function, Stage of Disease, and 
Depression 
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Associations between stage and sexual dysfunction and the differences from 
associations between stage and treatment need to be further studied in relation to sexual 
health. There are studies that have shown both variables are associated with dysfunction 
however, the relationship has not be separated in the literature. Therefore, the 
conclusiveness of the strong association with stage is hard to determine. 
In the literature, if information is gathered on stage, most focus is placed on 
participant's time since diagnosis and associations related to stage are not considered. 
However, similar to the results of this thesis, Tzung-Yi et aI. (2011) and Greenwald and 
McCorkle (2008) reported a significant association between stage of disease and sexual 
dysfunction. 
In the study by Tzung-Yi et aI., a cohort of Taiwanese women was investigated 
and the risk of sexual dysfunction with an increased stage was significantly increased 
(OR) (4.34,95% CI [1.65-19.09]). Separately, Greenwald et aI, found that when 
comparing invasive and noninvasive survivors, the noninvasive groups was less likely to 
report a negative impact on their sexual relationship. 
The finding of depression in association with sexual dysfunction is also consistent 
with the literature. Specific issues surrounding infertility, deterioration of relationships, 
body image, and self-esteem have all been shown to be associated with sexual 
dysfunction in cervical cancer survivors. (Bermark et aI., 1999; Baser, Li, and Carter, 
2012) These issues could all result in depressive symptoms that could ultimately lead to 
problems with sexual functioning. 
However, further research into the effect of depression on sexual health is 
required to separate the direction of causality. It is plausible that depression is causing 
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sexual dysfunction as well as sexual dysfunction is causing depression. Knowing which 
condition is causative to the other would help to adequately treat the problems in cervical 
cancer quality of life. 
5.2 Quality of Life and the MOS 36-item Short Form Survey (SF -36) 
The finding that women in this study were found to have generally higher scores 
on the SF-36 scale, indicating a higher level of quality of life, is consistent with the 
literature. For the total population, the mean scores for both the physical and mental 
health summary scores are 50 (SD 10) (Wenzel et aI., 2005) The mean scores reported by 
women in this study were higher. A review from Goncalves (2010) found that the same 
is true for most gynecological cancer studies. 
The associations found in this study between quality of life and depression and 
sexual dysfunction are also supported in the literature. For example, Wenzel et aI. (2005) 
found that better sexual functioning was positively associated with higher mental health 
summary scores. Also, Bartoces et aI. (2009) found an association with self-esteem and 
the mental health summary score. 
Contradictions in the literature occur when the association between quality of life 
and other covariates is investigated. Bartoces et aI. (2009) studied the difference in 
physical and mental health summary scores by stage and reported that there was not a 
difference between invasive and noninvasive groups. Alternatively, Frumovitz et aI. 
(2005) found that participants who were treated with radiation had a significantly lower 
physical health summary score. Lastly, Gotay et aI. (2008) found that when cervical 
cancer survivors were compared to a normative sample of women, survivors had higher 
mental health scores (SF-36 subscale). 
63 
5.3 Strengths and Limitations 
5.3.1 Limitations 
A clear limitation of this study is the cross sectional design which makes it 
impossible to determine the causal direction of the association between sexual 
dysfunction and depression. Does depression lead to an increased risk of sexual 
dysfunction, or is the dysfunction actually causing the depression? Also, in many cases 
the woman's sexual dysfunction could be a byproduct of her treatment for depression. 
(Basson, 2005) Therefore, while significant results were found, and support an 
association between sexual dysfunction and depression; further research is still needed to 
determine the true cause of both. 
The sample collected is also a limitation of this study. First, low response rate 
may be a source of selection bias in this study. Gi ven that so few women agreed to 
participate, it is plausible that the women that compose the sample are not representative 
of cervical cancer survivors. While the data collection process was designed to collect a 
random sample, the women who agreed to participate were in the minority. Also, the 
lack of in situ cases in the radiation treatment group, limits the ability of the study to 
make conclusions based on treatment and stage. Lastly, limited statistical power because 
of the small sample size is a limitation. Although, the associations found in this study 
were relatively strong. 
5.3.2 Strengths 
However, the study does add to the sparse literature that exists with regard to 
quality of life for cervical cancer survivors. In a 2006 review article by Vistad et aI., only 
23 studies relating to cervical cancer quality of life /including sexual dysfunction) were 
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published between 1966 and 2005. This included longitudinal studies, cohorts, and 
retrospective studies and only eight studies were considered to use acceptable 
methodology. (Vistad et aI., 2006) 
5.4 Future Implications 
The analyses conducted in this thesis prove a need for more focus to be placed on 
separating the effects that treatment and stage of disease have on sexual dysfunction. The 
strong association found between sexual dysfunction and stage of disease proves that the 
individual relationship should not be ignored. While treatment for cervical cancer 
becomes more aggressive with increasing cervical cancer stages, it has yet to be 
determined that stage itself does not have an independent effect. It is plausible that the 
effects of being diagnosed with advanced cervical disease cause sexual dysfunction, 
independently of treatment. However, because most of the research conducted focuses 
on the consequences of treatment, it is difficult to determine if stage has an effect or if the 
associations are a byproduct of treatment. Therefore, to adequately understand what 
causes sexual dysfunction more research should be conducted on comparing stage of 
disease with regard to sexual dysfunction. 
While the research and awareness of the issue of quality of life in cervical cancer 
survivors has increased and become a focus for researchers, there is still not much 
information available. (Goncalves, 2010) Significant associations exist between invasive 
cervical cancer survivors, treatment options, depression and sexual dysfunction, and also 
sexual dysfunction, depression, and quality of life scores. However, the relationships 
should be further explored. There are many aspects to these relationships that have been 
65 
left unexplained and therefore require more research to adequately help cervical cancer 
survivors in the future. 
66 
REFERENCES 
Abitbol, M. M. & Davenport, J. H. (1974) Sexual dysfunction after therapy for cervical 
carcinoma. American Journal of Obstetrics Gynecology, 119(2), 181-189. 
Advisory Committee on Immunization Practices (2011). Vaccines to Prevent Human 
Papilloma virus (Resolution No. 010/11-1 C.F.R.). Atlanta, GA: Centers for 
Diseases Control and Prevention. Retrieved from 
http://www .cdc.gov/vaccines/programs/vfc/downloads/resolutions/ 1 0 11-1-
hpv.pdf 
American Society of Clinical Oncology. (2012). Cervical Cancer. Retrieved from 
http://www.cancer.netipatientiCancer+ Types/Cervical +Cancer/ci. Cervical +Cance 
r.printer 
Bartoces, M. G., Severson, R. K, Rusin, B. A., Schwartz, K L., Ruterbusch, J. J., & 
Neale, A. V. (2009). Quality of life and self-esteem of long-term survivors of 
invasive and noninvasive cervical cancer. Journal of Women's Health, 18(5), 655-
661. doi: 10.1 089/jwh.2008.0959 
Baser, R. E., Li, Y., & Carter, J. (2012). Psychometric validation of the female sexual 
function index (fsfi) in cancer survivors. Cancer. doi: 1O.1002/cncr.26739 
Basson, R. (2005). Women's sexual dysfunction: revised and expanded definitions. 
Canadian Medical Association Journal, 172 (10) ,1327-1333. doi: 
10. 15031cmaj.1020174 
Baumgartner, K B., Fetherolf, J., Wheeler, c., Hunt, W. c., & Key, C. (2003). 
Adaptation and Quality of Life Among Long-Term Cervical Cancer Survivors 
Final Report (Contract NIHINCI, N01-PC-67007, Addendum 47. Submitted to 
Surveillance, Epidemiology, and End Results Program (SEER), National Cancer 
Institute. Albuquerque, NM: University of New Mexico School of Medicine. 
Bergmark, K, Avall-Lundqvist, E., Dickman, P.W., Henningsohn, L., & Steineck, G. 
(1999). Vaginal changes and sexuality in women with a history of cervical cancer. 
New England Journal of Medicine, 340(18), 1383-1389. 
67 
Bodurka, D. e., & Sun, e. e. (2006). Sexual function after gynecologic cancer. 
Obstetrics and Gynecology Clinics of North America, 33(4), 621-630, ix. doi: 
10. 10 16/j.ogc.2006.09.006 
Charlson, M. E., Pompei, P., Ales, K L., & MacKenzie, e. R. (1987). A new method of 
classifying prognostic comorbidity in logitudinal studies: Development and 
validation. Journal of Chronic Disease, 40(5), 373-383. 
Centers for Disease Control and Prevention (2012). Human Papillomavirus (HPV). 
Retreived from http://www.cdc.gov/hpv/cancer.html 
Centers for Disease Control and Prevention (2013). Genital HPV infection- Fact Sheet. 
Retrieved from http://www.cdc.gov/stdlHPV/STDFact-HPV.htm#a5 
Cohen, J. (1988). Statistical Power for the Behavioral Sciences. Hillsdale, NJ: Lawrence 
Erlbaum, INC. 
Donovan, K A, Taliaferro, L. A, Alvarez, E. M., Jacobsen, P. B., Roetzheim, R. 
G., & Wenham, R. M. (2007). Sexual health in women treated for cervical 
cancer: Characteristics and correlates. Gynecolic Oncology, 104(2),428-
434. doi: 1O.1016/j.ygyno.2006.08.009 
Eifel, P., Berek, J. S., & Thigpen, J. T. (2001) Cancer of the Cervix, Vagina, and Vulva. 
In DeVita, V., Hellman, K, Rosenberg, J.e. (Eds.) , Cancer Principles and 
Practice of Oncology (6th ed.) (pp. 1526-1550). Lippincott Williams and Wilkins. 
Ferrell, B. R., Dow, K H., & Grant, M. (1995). Measurement of the quality of life in 
cancer survivors. Quality of life research: an 1nternational journal of quality of 
life aspects of treatment, care, and rehabilitation, 4(6), 523-531. 
Frumovitz, M., Sun, e. e., Schover, L. R., Munsell, M. F., Jhingran, A, Wharton, J. T., . 
. . Bodurka, D. e. (2005). Quality of life and sexual functioning in cervical cancer 
survivors. Journal of Clinical Oncologyl, 23(30), 7428-7436. doi: 
10. 1200/jco.2004.00.3996 
Goncalves, V. (2010). Long-term quality of life in gynecological cancer survivors. 
Current Opinion in Obstetrics and Gynecology, 22, 30-35. 
Gotay, e. e., Farley, J. H., Kawamoto, e. T., & Mearig, A (2008). Adaptation and 
quality of life among long-term cervical cancer survivors in the military health 
care system. Military Medicine, 173(10), 1035-1041. 
Greenwald, H. P., & McCorkle, R. (2008). Sexuality and sexual function in long-term 
survivors of cervical cancer. Journal of Women 's Health, 17(6),955-963. doi: 
10.1 089/jwh.2007 .0613 
68 
Greimel, E. R., Winter, R., Kapp, K. S., & Haas, J. (2009). Quality of life and sexual 
functioning after cervical cancer treatment: a Long-term follow-up study. Psycho-
Oncology, 18(5),476-482. doi: 1O.1002/pon.1426 
Howlander, N., Noone, A., Krapcho, M., Neyman, N., Aminou, R., Altekruse, S., ... 
Cronin, K. (2012). SEER Cancer Statistics Review, 1975-2009 (Vinatage 2009 
Populations), National Cancer Institute. Bethesda, MD. Retrieved from 
http://seer.cancer.gov/csrI1975 2009 pops09/ 
Jensen, P. T., Groenvold, M., Klee, M. c., Thranov, 1., Petersen, M. A., & Machin, D. 
(2004). Early-stage cervical carcinoma, radical hysterectomy, and sexual function. 
A longitudinal study. Cancer, 100(1),97-106. doi: 1O.1002/cncr.11877 
Juraskova, 1., Butow, P., Bonner, c., Robertson, R., Sharpe, L. (2011). Sexual adjustment 
following early stage cervical and endometrial cancer: prospective controlled 
multi-centre study. Psycho-Oncology. Doi: 10.1002Ipon.2066 
Lindau, S. T., Gavrilova, N., & Anderson, D. (2007). Sexual morbidity in very long term 
survivors of vaginal and cervical cancer: A comparison to national norms. 
Gynecologic Oncology, 106(2),413-418. doi: 1O.1016/j.ygyno.2007.05.017 
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. 
(2007). Quadrivalent Human Papillomavirus Vaccine. MMWR 56(RR02), 1-24. 
McGregor, J. c., Kim, P. W., Perencevich, E. N., Bradham, D. D., Furuno, J. P., Kaye, K. 
S., ... Harris, A. D. (2005). Utility of the chronic disease score and Charlson 
Comorbidity Index as comorbidity measures for use in epidemiologic studies of 
antibiotic-resistant organisms. American Journal of Epidemiology, 161(5),483-
493. doi: 1O.1093/aje/kwi068 
McHorney, C. A., Ware, J. E., Lu, J. F. R., & Sherbourne, C.D. (1994). The MOS 36-
Item Short-Form Health Survey (SF-36®): III. tests of data quality, scaling 
assumptions and reliability across diverse patient groups. Medical Care, 32(4), 
40-66. 
National Cancer Institute (2012). HPV and Cancer. Retrieved from 
http://www .cancer. gov / cancertopics/factsheetlRisklHPV 
Park, S. Y., Bae, D. S., Nam, J. H., Park, C. T., Cho, C. H., Lee, J. M., ... Yun, Y. H. 
(2007). Quality of life and sexual problems in disease-free survivors of cervical 
compared with the general population. Cancer, 110(12),2716-25. 
Pieterse, Q. D., Maas, C. P., Ter Kuile, M. M., Lowik, M., Van Eijkeren, M. A., Trimbos, 
J. B., Kenter, G. G. (2006). An observational longitudinal study to evaluate 
miction, defecation, and sexual function after radical hysterectomy with pelvic 
lymphadenectomy for early-stage cervical cancer. International Journal of 
69 
Gynecological Cancer: Official Journal of the International Gynecological 
Cancer Society, 16(3), 1119-29. 
Radloff, L. S. (1977). The CES-D Scale. Applied Psychological Measurement, 1(3),385-
401. 
Schlesselman, J. (1974). Sample size requirements in cohort and case-control studies of 
disease. American Journal of Epidemiology, 99,381-384. 
Schlesselman, J. (1982). Case-control studies: Design, conduct, analysis. New York: 
Oxford University Press. 
Siegel, R., Naishadham, D., & Jemal, A (2012). Cancer statistics, 2012. CA: A Cancer 
Journal for Clinicians, 62 (1), 10-29. 
Sobin, L., Gospodarowicz, M., & Wittekind, C. (Eds.). (2002). UICC International 
Union Against Cancer: TNM Classification of Malignant Tumours (6th ed.), (pp. 
155-157). Geneva, Switzerland: John Wiley & Sons. 
Tangjitgamol, S., Manusirivithaya, S., Hanprasertpong, J., Kasemsarn, P., 
Soonthomthum, T., Leelahakom, S., ... Lapcharoen, O. (2007). Sexual 
dysfunction in Thai women with early-stage cervical cancer after radical 
hysterectomy. Journal of Gynecological Cancer: Official Journal of the 
International Gynecological Cancer Society, 17(5), 1104-12. 
Testa, M. A, & Simonnson, D. C (1996). Assessment of quality-of-life outcomes. The 
New England Journal of Medicine, 334 (13). 
The American Cancer Society. (2012, January). Treatment options for cervical cancer by 
stage. Retrieved from 
http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-
treating-by-stage 
Tsai, C, Bayliss, M. S., & Ware, J. E. (1997). SF-36® Health Survey Annotated 
Bibliography (2nd Ed.). Boston, MA: Health Assessment Lab, New England 
Medical Center. 
Tzung-Yi, T., Shu-Yi, C, Mei-Huei, T., Yi-Lin, S., Chih-Ming, H., & Hui-Fang, S. 
(2011). Prevalence and associated factors of sexual dysfunction in cervical cancer 
patients. Journal of Sexual Medicine, 8(6), 1789-1796. doi: 1O.11ll/j.1743-
6109.201O.0l74S.x 
Vistad, I., Fossa, S. D., & Dahl, A A (2006). A critical review of patient-rated quality of 
life studies of long-term survivors of cervical cancer. Gynecologic Oncology, 102 
(3),563-572. doi: 1O.1016/j.ygyno.2006.03.050 
70 
Vrzackova, P., Weiss, P., & Cibula, D. (2010). Sexual morbidity following radical 
hysterectomy for cervical cancer. Expert Review of Anticancer Therapy, 10(7), 
1037-1042. doi: 10. 1 586/era. 10.89 
Ware, J. E., & Sherbourne, C. D. (1992). The MaS 36-item short-form health survey 
(SF-36). 1. conceptual framework and item selection. Medical Care, 30(6), 473-
483. 
Ware, J.E., Gandek, B., & the IQOLA Project Group (1994). The SF-36® Health Survey: 
development and use in mental health research and the IQOLA Project. 
International Journal of Mental Health 23(2), 49-73. 
Ware, J. E. (n.d.). SF-36 Health Survey Update. Retrieved from http://www.sf-
36.org/tools/sf36.shtml 
Waterhouse, J., & Metcalfe, M. (1986). Development of the sexual adjustment 
questionnaire. Oncology Nursing Forum, 13(3),53-59. 
Waterhouse, J., & Metcalfe, M. (1991). Attitudes toward nurses discussing sexual 
concerns with patients. Journal of Advanced Nursing, 16(9), 1048-1054. 
Wenzel, L., DeAlba, 1., Habbal, R., Kluhsman, B. c., Fairclough, D., Krebs, L. U., ... 
Aziz, N. (2005). Quality of life in long-term cervical cancer survivors. 
Gynecologic Oncology, 97(2), 310-317. doi: 1O.1016/j.ygyno.2005.01.010 
World Health Organization. (2012, November 11). BMI classification. Retrieved from 
http://apps.who.intibmi/index.jsp?introPage=intro 3.htrn1 
WHOIICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) 
(2010). Human Papilloma virus and Related Cancers in World (Summary Report 
2010). Retrieved from www.who.intlhpvcentre 



















APPENDIX A: VARIABLE DESCRIPTIONS AND CODING 
VARIABLE DESCRIPTIONS AND CODINGa 
Range of Answers Description 
Excellent-Poor Subjects opinion on current health 
Much better now-much worse now Subjects opinion on current health as compared to I 
~ear ago 




Several flights of stairs 



















PAINRLTD Cervical disease or other? 








Walking I mi+ 
Walking several hundred yards 
Walking 100 yards 
Bathing and dressing 
Did the subject experience problems with work /daily 
activities due to emotional problems during last 4 
weeks 
Cut down on amount of time spent on work 
Accomplished less than desired 
Less careful with work/activities 
Physical/emotional health's interference with normal 
social life 
Bodily pain in last 4 weeks 
What is pain related to 
Feelings over last 4 weeks 
.......... 
Full of pep? 
Been nervous? 
Down and nothing heightens spirit 
Felt calm? 








4WK_NTRF all time-none time 
Section 1- Diagnostic and Treatment Information 
DTI Yes or No 
INVASIVE 
CIS 
DT4 SURG_TX Yes or No 
SURG_OVR Yes or No 
AFTR_OVR Yes or No 








DIAR_BWL Yes or No 
NABLBLDR Yes or No 
Been happy? 
Felt tired? 




Surgery as treatment 
Ovaries removed during surgery 







Specification of other 



























Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 
Yes or No 













Paralysis due to stroke 
Asthma 
Emphysema, chronic bronchitis, COPD 



























OS TO PROS 
DPRSSN 
Yes or No Lupus 
Yes or No Polymyalgia rheumatica 
Yes or No Comorbidities 
Cirrhosis or liver damage 
Leukemia or polycythemia vera 
Lymphoma 
AIDS 
High BP or Hypertension 





Chronic Nervous condition 






DPRSRLTD Depression related to Cervical disease or cervical 
cancer 
OBESITY Obesity 
OTHR_CA Other Cancers 
CA_TYPES Specify Cancer 
OTHR_HLT Other health problems 
MCII STDS and Year of diagnosis 
GEN_WRTS Yes or No Genital Warts 
GEN_HRPS Yes or No Herpes 
TRCOMNAS Yes or No Trichomonas 
-....) 
-....) CHLAMDIA Yes or No Chlamydia 
GONORHEA Yes or No Gonorrhea 
SYPHLIS Yes or No Syphilis 
PIO Yes or No Pelvic Inflammatory Disease 
HPV Yes or No Human papillomavirus 
Section 2- Thought and Attitudes 
TAl Excellent-Poor Rating QOL (excellent-poor) 
QOL2Y @ 2 years 
QOL_NOW Now 
TA2 QOL_CVCA Yes or No Current QOL impacted by Cervical Disease 




Bothered by things that usually are not bothersome? 
Poor appetite 
Could not shake off blues 
Felt just as good as everyone else 
Trouble with focus 
Felt depressed 
Everything was an effort 
Felt hopeful 
Life been a failure 
Felt fearful 
Sleep was restless 
Felt happy 
Talked less than usual 
Felt lonely 
People were unfriendly 
Enjoyed life 
Had crying spells 
Felt sad 
Felt people disliked them 
Could not get going 
-....l 
1.0 
Section 3- Screening, Reproductive, and Menstrual History 




RS8 SEXIMPNW Extremely- of No Importance 
RS9 SEXNJYNW Always-No activity 
RSIO SEX_DESR Always-Never 
RSII DSR_OFfN Always- Never 
RSl2 SEX_SAT Al ways-Never 
RSl3 FREQ_SAT Very satisfied- Very unsatisfied 
RSl4 SEX_TENS Always- never 
RSI5 CAFX_SEX Very bad-very good 
RSI6 ADX_MENS Currently having periods- no longer 
having periods 
RS17 NOW_MENS Currently having periods- no longer 
having periods 
RS18 HSTRCTMY Yes or No 
RS24 TX_NFRTL Yes or No 
FRTL_TX Yes or No 
RS25 NFRTLRSK Yes or No 
Intercourse with man? 
Age of I st time 
# of men before diagnosis 
# of men after diagnosis 
Importance of sex 
How often is sex enjoyable 
Desire for sex 
Desires for sex is greater than partner's desire 
Satisfied after sexual activity 
Satisfied with frequency 
Tense after sexual experience 
Effect of diagnosis on sexual relationship 
At time of diagnosis, what was menstrual status 
Now what is menstrual status 
Hysterectomy 
CC treatment render infertile 
Fertility treatments tried 
Discussion of infertility risks with physician 
Section 3- Health and Family History 
HFI HGHT_Ff feet Current height 
HGHT_IN inches 
HF3 NOW_WGT lbs Current weight 
Section 4-Lifestyle Information 
LII SMOK_LIF Yes or No Have your smoked at least 100 cigarettes in lifetime 
NOW_SMOK Every day, some days, not at all Currently smoke 
LI2 HAD_DRNK Yes or No I drink in last month 
LI9 PA_MONTH Yes or No Physical activity in last month 
00 
o Section 4- Demographic Data 
DDI DOB Date of Birth 
AGE Years old 
DD3 MARR_ADX Married, widowed, divorced, Married at diagnosis 
separated, other, never married 
MARR_NOW Married, widowed, divorced, Married now 
separated, other, never married 
DD5 NOW_SCHL 81n grade or less, some high school, Level of schooling completed 
high school grad, some college, 
college grad, grad school 
DD8 NOW_INCM Pick code Pretax Income now 
DD9 NO_INS Yes or No No insurance 
DDI2 SLF_ETHN Ethnicity 
"All variables included in dataset. Not all were included in analysIs 
APPENDIX B: CERVICAL CANCER STUDIES 
Cervical Cancer Studies a 
Author Design Aims Cancer Types Treatment Types Results Covariates 
Abitol and Clinical I. Effect of therapy Invasive Only • Radiation (28) • 22128 subjects given radiation None Available 
Davenport Series on sexual • Surgery (32) had anatomical changes 
00 (1974) function • Combination sufficient to cause sexual 
2. Associations with (15) dysfunction 
changes in • 2/32 surgical patients had 
vaginal anatomy changes in anatomy sufficient 
to cause sexual dysfunction 
• Combination treatment group 
33% with sexual dysfunction 
Bartoces, Case-Case I. Determine • Invasive (42) Surgery Only • Invasive group more likely to Factors associated 
Serverson, Comparison quality of life • Noninvasive report income of < $10,000 with quality of life 
Rusin, differences (103) • Invasive group NOT (socioeconomic 
Schwartz, between invasive associated with ethnicity, age, factors, behavioral 
Ruterbusch, and and noninvasive education, health insurance, characteristics, 
Neale long term marital status, comorbidities, psychosocial factors, 
(2009) cervical cancer relapse or HRT; and comorbidities) 
survivors 
• Similar self- esteem between 
2. Evaluate both groups 
associations 
between quality 




















Establish the validity • 
and reliability of the 
Female Sexual 
Function Index (FSFI) 





1. Prevalence of • 
symptoms and 
reduced function 









women to trade 
years of life for 
better quality of 
life 
4 cohorts from • Surgery • Cronbach a reliability score None Available 
3 studies with • Chemotherapy was 0.94 








Early Stage • Surgery • 19% of cases and 3% controls • Demographic 
Cervical Cancer • Radiotherapy with lymphedema (25% of characteristics 
(93) cases found it distressful) • Treatment 
Matched • Risk of inability to completely • Medications and 
controls (350) void urinary bladder was 9 Preexisting 
times higher for cases than conditions 
controls • Cancer relapse 
• 19-35% of sexually active • HRT 
cases reported changes in 
vaginal anatomy 
• Higher levels of distress with 
regard to sexual functioning 



























Determine if • Cervical cancer 
women treated patients with 
for cervical stages 0-11 (50) 
cancer have • Age matched 
poorer sexual controls (50) 
health 
Determine if the 
differences in 





Compare quality • Cervical Cancer 
of life and sexual patients with 
functioning in tumors :56cm 
cervical cancer (74) 
survivors who • Age and race 
received different matched 
treatment Controls (40) 
• Surgery • Cases had significantly higher • Demographics 
• Radiation mean scores in sexual • Clinical 
• Chemotherapy disinterest (7.5 ±2.9) and characteristics 
• Combination dysfunction (9.6±3.8) and • Physical factors 
significantly lower mean 
• Psychosocial 
scores in satisfaction (3.9±2.1) factors 
• Covariates associated with 
decreased sexual function and 
interest: less education, recent 
diagnosis, radiation, poor 
partner relations, negative 
self-esteem, anatomical 
changes 
• HRT increased sexual interest 
• Surgery (37) • Radiation group had higher • Age 
• Radiation (37) stage of disease (p <0.001) • Marital Status 
• Radiation group scored worse • Religion 
for physical health scores • Education 
(45.1 p<O.OOl) 
• BMI 
• Radiation group had overall • Current smoking 
poorer sexual function as habits 




















Assess quality of • Invasive Only 
life of long term (41) 
cervical cancer • SF-36 scores 
survivors in the compared to 
military health scores gathered 
system from 
Assess the respondents to 
ability of the National 
researchers to use Health Survey 
the Department of Functional 

















on self-image and 
sexuality 
Not an outcome • Survivors had a higher overall • Demographic 
variable mental health scores data (age, 
(52.38±9.35) as compared to religion, 
general population education, marital 
• 44% of survivors indicated status, income, 
cervical cancer had a negative health and life 




• Clinical variables 
(treatments 
recei ved and 
medications) 
• Comorbidities 
• Social support 
• Surgery • Income ~$ 60,000 (OR 0.26), • Demographics 
• Radiation Caucasian race (OR 0.16), and • Health status 
• HRT diagnosis in stage I (0.38) • Emotional state 
significantly predict sexual 
• Health behaviors 
outcomes. 
• Family life 
• Hysterectomy reduced the • Lifestyle likelihood of decreased 
• Employment desire(OR 0.26) status 
• Hysterectomy with 
oophorectomy increased risk 
of lack of enjoyment ( OR 
21.10) 
• 34% of subjects reported 
cervical cancer had a negative 



















Case- Determine the long-
Control term side effects of 
treatment options on 
cervical cancer 
survivors quality of 
life and sexual 
functioning 
Case- Describe the impact 
Control of the radical 
hysterectomy on 
sexual function 
Case- Evaluate sexual 
Control adjustment of women 
with early stage 
cervical and 
endometrial cancer 
Cervical Cancer • 





Stage I or II • 
• 
• Stage I or II • 
endometrial or 









Surgery alone • When compared with other • Socioeconomic 
(63) treatment groups, women who variables 
Surgery and underwent surgery and • Medical variables 
Chemotherapy radiation therapy had 
(38) significantly worse mean 
Surgery and scores for several quality of 
Radiation (20) life outcomes. 
• Surgery and radiation group 
reported significantly lower 
frequency of sexual activity 
than other two groups (p 
0.006) 
Radical • Cases were found to be at • Socioeconomic 
hysterectomy increased risk of several factors 
(173) symptoms of sexual • Menopausal 
Age-matched dysfunction throughout the status 
controls (328) different time periods. The • HRT 
relative risk for these 
symptoms ranged from 1.2-4.1 
depending on the symptom 
and time since treatment. 
Radical No significant differences among • Socioeconomic 
hysterectomy groups factors 







































sexuality of long 




• Evaluate the care 
received for 
sexual problems. 
Compare quality of 
life and sexual 
function in cervical 
cancer survivors 






treatment of cervical 






• Adenocarcinom • Surgery 





• Stage I-IV • Surgery only 
cervical cancer • Surgery and 
survivors (860) radiation 
• Age-matched • Radiation only 
controls (494) 
• Stage I-IIA • Radical 
(73) hysterectomy 








• Higher prevalence of sexual • Socioeconomic 
problems among cases (p characteristics 
0.02- <0.001) • HRT 
• Frequency of sexual activity • Partner status 
lower in cases than in controls • Self-reported 
(p 0.002) health 
• Increased risk of several • Patient-Physician 
sexual problems found in communication 
cases (odds ratios range from regarding sex life 
2.33-10.47) changes 
• Cases scored more poorly than • Socioeconomic 
controls in several areas characteristics 
• Radiation group had poorer • Clinical 
emotional functioning scores information 
(p <0.01) • Religion 
• When all treatment groups • Comorbidities 
were compared to controls, • Physical activity 
cases had several symptoms of 
• Tobacco and 
poor quality of life and sexual alcohol use 
dysfunction 
• Cases were at increased risk of • Age 
sexual dysfunction and • HRT 
dissatisfaction after surgery, • Marital Status 
regardless of radiation 
(Relative Risk 3.3-4.3) 
• Risk of dissatisfaction with 
sex life increased as the post 
treatment time increased 
(Relative Risk 4.1-7.6) 
• Radiation therapy with surgery 
increased the risk of no sexual 
activity (Relative Risk 1.9) 
• Participants were found to • Variables relating 
have an increase in sexual to home life 
dysfunction symptoms post- • Comorbidities 




























in women with early 
stage cervical cancer 
in Thailand 
Evaluate chronic • Stage Ib2-IVa • Radiation 
fatigue and other (91) 
variables in cervical • Normative data 
cancer survivors who 
were 5 years post-
treatment and were 
treated with radiation 
therapy. 
Investigate the QOL • Cervical Cancer • Surgery only 
in cervical cancer cases (51) • Surgery and 
survivors (5- 10 years) • Acquaintance Radiation 
that were also of controls (50) • surgery and 
childbearing age chemotherapy 
• Radiation only 
• HRT was associated with an • Menopausal 
increased risk for a decrease in Status 
sexual frequency (OR 6.20 P • HRT 
0.010) • Socioeconomic 
• Salpingo-oophorectomy was factors 
found to increase the risk of a 
decrease in sexual frequency 
(OR 2.42 p 0.033) 
• 30% of the sexually active • Demographics 
subjects were sexually active • Clinical 
versus 53% of the normative characteristics 
sample • Psychological 
• Significantly lower mean characteristics 
score for pleasure (p 0.01) and 
higher mean score for 
discomfort (P <0.001) during 
sexual activity 
• Anxiety and depression was 
more common among cervical 
cancer survivors with chronic 
fatigue than those who did not 
have chronic fatigue. 
• Overall mean scores for • Demographics 
quality of life were similar for • Socioeconomic 
cases and controls. factors 
• Distress among survivors was • Cancer specific 
significantly associated with distress 
age (p <0.0 I), social support • Social support 
(p < 0.001), more reproductive • Spirituality 
concerns (p <0.001), worse 
• Reproductive 
mental status (p <0.0001), and concerns 
less spirituality (p < 0.01) 
• Gynecologic 
• 31 % of cases were not functioning 
sexually active 
• HRT 
• Several gynecologic problems 
were found more common in 
00 
00 
Tzung-Yi, T., Cross- Determine the • Stage I or 
Mei-Huei, T., Sectional prevalence of sexual below (70) 
Yi-Lin, S., dysfunction in Taiwan • Stage II or 
Chih-Ming, G., and the factors above (35) 
& Hui-Fang, S. associated with sexual 
(2011) dysfunction 
Vrzackova, Review Describe female Not applicable 
Weiss, & sexual dysfunction in 
Cibula cervical cancer 
patients treated with 
radical hysterectomy 
"Refer to Reference List for more information about articles 
cases than controls (p values 
ranging from 0.0143-0.0166) 
• Cases who reported sexual 
dysfunction were found to 
have lower mean scores for 
quality of life (D <0.01) 
• One form of • Increased risk of sexual • Demographics 
treatment only dysfunction later stages • Sexual 
• Multiple forms counseling 
of treatment • Employment 
status 
• Menstrual status 
• Educational 
Level 
Not applicable • Female Sexual Dysfunction in Not applicable 
short term survivors found by 
Jensen et al. 
• Desire and Interest impacted 
byHRT 
• Surgery associated with 
decreased interest 
• Dypareunia, orgasmic 




APPENDIX C: SEXUAL HISTORY QUESTIONS AND RESPONSES 
Sexual History Questions and Responsesa,b 
Question Response 





Of no Importance 
Missing 






No Sexual ActivitylNo partner (s) 
Missing 























Do you desire sexual activity more of than your partner? 
Do you feel satisfied after sexual activity? 
Are you satisfied with the frequency of sexual activity in your life? 
























































No Sexual Activity/ No partner(s) 
Missing 
What effect has your diagnosis of cervical diseaselcancer had on your 
sexual relationship with your partner(s)? 
Very Bad Effect 
Some Bad Effect 
No Effect 
Some Good Effect 
Very Good Effect 
No Partner 
Missing 
Composite Variablec Positive Response to all 8 questions 
Negative Response to all 8 questions 
Missing 
aSexual History questions found in New Mexico Community Health Survey (Baumgartner et aI., 2003) 
bAll questions originally from the Sexual Adjustment Questionnaire (Waterhouse & Metcalfe, 1986) 
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APPENDIX D: TREATMENT OPTIONS BY STAGE OF DISEASE 
TREATMENT OPTIONS BY STAGE OF DISEASJtI 
Stage Sub- Treatment Options 
categories 
Stage 0 • For carcinoma in situ, Cryosurgery, Laser surgery, LEEPILLETZ, 
or Cold knife conization 
• For adenocarcinoma in situ, a hysterectomy or a cone biopsy until 
preserving fertility is not an issue and then a hysterectomy 
Stage IA IAl • To Preserve fertility, cone biopsy with close observation for 
reoccurrence 
• Hysterectomy 
• If cancer has invaded blood or lymph vessels and fertility needs to 
be preserved, radical trachelectomy and removal of pelvic lymph 
nodes 
• If cancer has invaded blood or lymph vessels and fertility does not 
need to be preserved, radical hysterectomy and removal of pelvic 
lymph nodes. 
IA2 • Radical hysterectomy and removal of pelvic lymph nodes 
• Brachytherapy with or without external beam radiation to the 
pelvis 
• If preserving fertility, radical trachelectomy with removal of 
pelvic lymph nodes 
Stage IB IBl • Radical hysterectomy with removal of pelvic lymph nodes (some 
para-aortic lymph nodes can be removed as well) 
• Radiation with brachytherapy and external beam radiation 
• If preserving fertility, radical trachelectomy with removal of 
pelvic lymph nodes (some para-aortic lymph nodes may need to 
be removed as well) 
IB2 • Brachytherapy with Cisplatin chemotherapy and radiation 
• Radical hysterectomy with removal of pelvic lymph nodes 
(radiation is sometimes needed depending on whether or not 
cancer is found in the lymph nodes) 
• Radiation followed by a hysterectomy 
92 
Stage II lIA • Brachytherapy and external radiation if tumor is greater than 4 cm 
along with cisplatin chemotherapy 
• Radiation and removal of the uterus 
• Radical hysterectomy and removal of lymph nodes if tumor is less 
than 4cm (with the possibility of radiation, chemotherapy and 
brachytherapy) 
lIB • Internal and external radiation and cisplatin 
Stages III • Internal and external radiation with cisplatin 
and IVA 
Stage • Radiation to relieve symptoms and chemotherapy 
IVB 
aAdapted from the Amencan Cancer Society (2012) 
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